Activity Report 2022-2023

["Gnanavelu S, Boopalan S, Ponnat AK, Joseph S, Sundar B, Rashme VL, Nunez do Rio JM, Nderitu P, Raman Puthuran GV, Krishnadas SR, Mishra C. Venkatachalam S, Ehrlich JR, Ravilla T. R, Rajalakshmi R, Kim R, Rani PK, Angle-closure glaucoma secondary to Accuracy of a low-cost, portable, refractive Sivaprasad S, Bergeles C; SMART India malignant hypertension- A difficult conundrum. error estimation device: Results of a diagnostic Study Group. Ophthalmol Glaucoma. 2022 Sep- accuracy trial. Using deep learning to detect diabetic Oct;5(5):554-556. PLoS One. 2022 Aug 3;17(8):e0272451. retinopathy on handheld non-mydriatic retinal images acquired by field workers in community Vishwaraj CR, Vellam VR, Srinivasan K. Ramke J, Silva JC, Gichangi M, Ravilla T, settings. Secondary Angle Closure Mimicking Burn H, Buchan JC, Welch V, Gilbert CE, Sci Rep. 2023 Jan 25;13(1):1392. Aqueous Misdirection. Burton MJ; Ophthalmol Glaucoma. 2022 May- Cataract Access Study Group. Cataract Coan L, Williams B, Krishna Adithya V, Jun;5(3):312. services for all: Strategies for equitable access Upadhyaya S, Czanner S, Venkatesh R, from a global modified Delphi process. Willoughby CJ, Kavitha S, Czanner G. Ganesan N, Kakarla H, Narayana S. PLOS Glob Public Health. 2023 Feb Automatic detection of glaucoma via fundus Immune Keratitis Heralds HLA-B27 22;3(2):e0000631. imaging and artificial intelligence: A review. Associated Peripheral Spondyloarthropathy. Surv Ophthalmol. 2023 Jan-Feb;68(1): Ophthalmology. 2022 Apr;129(4):387. Manayath GJ, Verghese S, Narendran V. 17-41.\t\t Multimodal imaging of Unilateral Idiopathic Balakrishnan H, Ganesan V, Sivakumar R. Macular Telangiectasia Type 2 - A five-year Kogachi K, Lalitha P, Prajna NV, A Case of Pupillary Ruff Detachment. study. Gunasekaran R, Keenan JD, Campbell JP, Ophthalmology. 2023 Jan;130(1):86.\t Retin Cases Brief Rep. 2022 Aug 25. Song X, Redd TK. [Epub] \t\t\t\t Deep Convolutional Neural Networks Detect Gurnani B, Kaur K, Agarwal S, Lalgudi no Morphological Differences Between Culture- VG, Shekhawat NS, Venugopal A, Kathirvel K, Karen L, Haribalaganesh R, Positive and Culture-Negative Infectious Tripathy K, Srinivasan B, Iyer G, Gubert J. Krishnadas R, Muthukkaruppan V, Lane Keratitis Images. Pythium insidiosum Keratitis: Past, Present, B, Simpson DA, Goljanek-Whysall K, Transl Vis Sci Technol. 2023 Jan 3;12 and Future. Sheridan C, Bharanidharan D, Willoughby (1): 12. Ophthalmol Ther. 2022 Oct;11(5):1629- CE, Senthilkumari S. 1653. Short and long-term effect of dexamethasone Morya AK, Janti SS, Sisodiya P, Tejaswini on the transcriptome profile of primary human A, Prasad R, Mali KR, Gurnani B. Kaur K, Gurnani B, Nayak S, Deori N, trabecular meshwork cells in vitro. Everything real about unreal artificial Kaur S, Jethani J, Singh D, Agarkar S, Sci Rep. 2022 May 18;12(1):8299. \t intelligence in diabetic retinopathy and in Hussaindeen JR, Sukhija J, Mishra D. ocular pathologies. Digital Eye Strain- A Comprehensive Review. Kalaimani L, Devarajan B, World J Diabetes. 2022 Oct 15;13(10): Ophthalmol Ther. 2022 Oct;11(5):1655- Namperumalsamy VP, Veerappan M, 822-834. 1680. Daniels JT, Chidambaranathan GP. Hsa-miR-143-3p inhibits Wnt-\u03b2-catenin and Jeyaprakash K, Thirumalairaj K, Kim U, MAPK signaling in human corneal epithelial Muthukkaruppan V, Vanniarajan A. stem cells. RB1 transcript analysis detects novel splicing Sci Rep. 2022 Jul 6;12(1):11432. aberration in retinoblastoma. Pediatr Blood Cancer. 2023 Jun;70(6): e30290. 51","LAICO works beyond the borders of Aravind to enhance eye care service delivery through training, capacity building, mentoring and advocacy. Over the past year, LAICO has worked both on developing its own capacity through internal training programmes and has developed innovative strategies to achieve greater impact for its partner hospitals. Consultancy and Capacity Building 52","Consultancy and Capacity Building The collaborative helped improve the service delivery of 24 existing vision centres and facilitated LEAP collaborative series the establishment of 14 new centres by the partner hospitals. A total of 51,411 outpatient visits and 4,907 LAICO\u2019s collaborative series under the banner LEAP, cataract surgeries were recorded by existing vision aims to bring about improvements in specific functional centres, representing growth rates of 27% and 50%, areas of eye hospitals through a collaborative method. respectively. Additionally, newly established vision These collaboratives employ the principles of Model centres recorded 13,867 out-patient visits and 612 for Improvement, Plan-Do-Study-Act (PDSA) cycles, cataract surgeries, bringing the combined additional and continuous process improvement as strategies to cataract surgeries to 2,248. achieve partners aims. LAICO launched its second batch of the LEAP Support for free cataract surgeries NABH collaborative series on 27th February 2023. Five As part of the CSR activity, BOSCH, a leading hospitals that are preparing for entry level certification global supplier of technology and services, has been have enrolled in this programme. The timeline of the collaborating with LAICO to provide free cataract collaborative series was reduced from 12 months to 8 surgeries across India. As part of the third phase of this months starting from March till October 2023. Gap project, LAICO identified 24 potential partners in 12 assessment visits were made to all five hospitals. states and supported a total of 3,840 cataract surgeries. The second batch of LEAP collaborative, aimed at The project came to an end in March 2023. improving the performance of existing vision centres and establishing new ones, came to an end in November Project UP Sight 2022. It consisted of four learning sessions, which provided a platform for sharing experiences and best As an ongoing support to Sitapur Eye Hospital (SEH), practices among the partner hospitals. A total of 17 Uttar Pradesh, LAICO continues to undertake various hospitals from India, Africa, and Bangladesh took part. initiatives both at the strategic and operational levels LAICO team visited 22 vision centres run by seven to strengthen the leadership team, hospital operations partner hospitals and suggested recommendations for and build the HR capacity. Aravind\u2019s doctors were sent improvement. It also assessed the location identified to SEH to support the team in performing speciality for establishing a vision centre by Grameen GC Eye surgeries. A set of staff went to help with IT system Hospital in Bangladesh. upgrade and electronic medical record implementation; streamline inventory management and operation theatre processes. Aravind\u2019s senior team periodically visited the hospital to see its progress and suggest ways for Dhivya Ramasamy, Dr. Indiradurai and Shobanadevi during their visit to vision improvement. LAICO facilitated a centre of Grameen Eye Hospital, Bogra, Bangaldesh for onsite technical support goal setting workshop for the entire team of SEH on 15 and 16 February 2023. Following this, a three member leadership team, Dr. (Col) Madhu Bhadauria, Director RIO, SEH Trust; Dr. (Brig) V.K. Baranwal, Chief Medical Officer, SEH and Deepak Kanade, Chief Administrative Officer, SEH visited Aravind-Madurai during 13-14 March 2023 to discuss institution building and the way forward. Staff of SEH belonging to different cadres were also given training in their respective areas at Aravind. 53","Facilitating visioning process Capacity building visits LAICO offered inputs to the senior teams of various Eye Foundation Community Hospital, Ijebu, organisations who wished to replicate the Aravind Nigeria model in their own settings and also brainstormed the prospects of future collaboration. It also supported its 11-16 July 2022 partner hospitals that have had a leadership transition LAICO Consultancy team analysed the performance of recently, for a comprehensive long-term planning the hospital and its vision centres. Discussions revolved and for creating buy-in amongst the stakeholders in around the barriers in outreach eye care programmes, developing a shared vision for the future. Towards this, improving patient volume in vision centres and opticals LAICO facilitated visits by the senior leadership teams acceptance rate. from the following hospitals and organisations: -\t LEPRA Society, Hyderabad, 23-27 August Tulsi Chanrai Foundation Eye Hospital, Abuja, -\t SEVA Foundation, Nepal, 10-13 October Nigeria -\t RR Lions Eye Hospital, Palakol, Andhra Pradesh, 17-19 July 2022 21-22 October During the visit, a detailed capacity assessment was -\t Akhand Jyoti Eye Hospital, Mastichak, Bihar, done to assess the gap, for performing 10,000 surgeries a year. Detailed analysis of outpatient patterns was done 30 October-5 November and opportunities for improving outpatient flow to -\t Grameen Health Care Services, Dhaka, Bangladesh, manage patient volume and cycle time were discussed. The team analysed refraction and optical sales data and 20-24 November presented the gap in optical services to plan for working -\t Fernandez Foundation Maternity Services, on specific areas and improving the acceptance rate. Hyderabad, Telangana, 16-19 November Jorhat Lions Eye Hospital, Jorhat, Assam -\t International Smart Card (ISC), Baghdad, Iraq, 16-19 July 2022 18-20 March (who are planning to set up an eye As part of the Lavelle capacity building project, hospital) LAICO team made a follow up visit to the hospital to understand the current practices and processes and Team from International Smart Card with Aravind senior leaders and staff 54","Visit to Sudarshan Netralaya - Dr. Kalpana inspecting the site for Dr. V.R. Vivekanandan, K.M. Sashipriya and R. Suganya during expansion of hospital their visit to Shardha Netralay facilitate a discussion towards improving its day to day the planning exercise, the visiting team assessed the management. implementation of activities recommended in 2019 and the gaps that need to be addressed immediately. Sudarshan Netralaya, Amreli, Gujarat Cape Coast Teaching Hospital, Cape Coast, Ghana 17-18 October 2022 Aravind consultancy team visited the hospital to 5 - 11 February 2023 understand the hospital\u2019s growth potential, current Aravind Consultancy team visited the hospital to gaps and challenges and develop an action plan to provide inputs on developing it to become a centre of address these. The team conducted a full-fledged excellence in eye care. performance review on various indicators after understanding and analysing the annual performance Internal capacity building data. They also analysed the hospital\u2019s infrastructure requirements and the need for adding more services in LAICO facilitated a course on Lean Six Sigma Green the near future. Belt, a popular process improvement methodology that combines the principles of Lean and Six Sigma to Shardha Netralay, Dhule, Maharashtra improve quality, reduce waste, and increase customer satisfaction. LAICO faculty as well as managers of 12-16 December 2022 Aravind Eye Hospitals took part in this virtual course LAICO team visited the hospital to guide the team to which had five classes, each of 3-hour duration, during develop a strategic plan that will help it to become a January to February 2023. A total of 15 people took high-volume tertiary eye care centre. As a first step of part. This comprehensive training programme covered various aspects of improvement, including statistical B.S. Ganesh Babu, Dr. Rohan Daniel with Dr. Kunle Hassan at analysis, process mapping, project management, and eye foundation community hospital change management. Peria Regupathy, a certified Lean Six Sigma Master Black Belt and Champion handled the session. ACCESS project wrap-up meeting Aravind Eye Care System has been working with five partner hospitals in sub-Saharan Africa, from Kenya, Zambia, Ethiopia and Nigeria since 2012 through the ACCESS Initiative (African Centres of Excellence in Cataract Services). This project was supported by Hilton Foundation through two grants that concludes in May 2023. The final meeting of the ACCESS initiative was held at LAICO from 20-25 March. The team from 55","ACCESS Project wrap-up meeting from regional resource centres to develop curriculum for effective patient communication and counselling. Nigeria joined the meeting via zoom. A senior leadership LAICO will also help develop a full-fledged training team from the Cape Coast Teaching Hospital, Ghana package for the resource centres to carry forward and and representatives from HCP Cure Blindness also deliver in their respective regions. joined the meet. Aurosiksha Teaching and Training Aurosiksha, Aravind\u2019s online portal for Mid Level Curriculum development workshop for patient Ophthalmic Personnel (MLOP) is making steady communication and counselling progress towards its goal of developing Aravind as a centre of Excellence in MLOP training and becoming Orbis-India has taken the initiative to develop the a resource centre for MLOP training. Subscribers of following four hospitals as regional resource centres Aurosiksha\u2019s training resource library have increased to deliver training related to patient counselling and to 9555. With training materials uploaded for 23 patient communication: competencies this year, Aurosiksha now offers a library -\t Dr Shroff\u2019s Charity Eye Hospital, Daryaganj, Delhi of training materials for over 170 competencies. -\t Netra Nirmay Niketan, Chaitanyapur, West Bengal -\t Little Flower Eye Hospital and Research Centre, Aurosiksha\u2019s learning management system (LMS) helps eye hospitals manage the delivery of MLOP Ernakulam, Kerala training. The LMS features online tests, a digital - \t PBMA\u2019s H V Desai Eye Hospital, Pune, Maharashtra skill assessment tool, classroom session scheduling, attendance tracking, and the entry of formative and At the three-day workshop organised from 19-21 summative assessment scores. During April 2022 December LAICO brought together experts in the field to March 2023, 1,936 new users have begun using of patient communication along with representatives Aurosiksha\u2019s LMS, taking the total number of users to 5308. Participants of curriculum development workshop In addition, monthly online quizzes - on topics such as spectacles and contact lens dispensing, ocular chemotherapy - with over 500 responses each month, contribute to continued learning for MLOP. In order to further enhance their knowledge, fortnightly microlearning titbits called Siksha Bites have been launched. AIOS-ARC leadership development programme Every year, the Academic and Research Committee (ARC) of All India Ophthalmological Society (AIOS) 56","Participants of AIOS-ARC leadership development programme GSI partners meet organises Leadership Development Programme (LDP) retinopathy of prematurity. Introduction of eyeNotes for a cohort of ophthalmologists who wish to improve (Aravind developed electronic medical record system) their practice management and leadership skills. In the enabled it to capture more accurate patient information last year, LAICO conducted this programme on 10th- and make them available in a timely manner. The 11th September. About 30 ophthalmologists who were workshop was organised to brainstorm how AI can be the participants of LDP (2020-21 and 2021-22) took leveraged on the clinical and nonclinical areas of patient part. The programme discussed topics such as building care with a view to enhance overall performance. a high-performing team; sustainable drivers of revenues Twenty two staff from various Aravind centres took and profits; quality and challenges ahead. part. Senior consultants from iMerit, an AI data solutions firm-Dr. Jaideep Jesson Rayapudi and Vibhor October Summit 2022 Goel handled various sessions. Leveraging Artificial Intelligence (AI) and GSI partners meet enhancing performance LAICO, 10- 11 October 2022 Aravind has been exploring the possibilities of adopting After a gap of three years, it was time to resume AI for improving eye care and has made significant fellowship with all partners in Seva\u2019s Global Sight progress in the screening of diabetic retinopathy and Initiative (GSI) network. Twenty participants from Dr. G. Natchiar addressing the participants at the workshop on operational excellence 57","nine hospitals and two representatives from SEVA Health Services Research foundation took part. The meeting analysed the performance of partner hospitals on various metrics and LAICO\u2019s Research Division assisted international explored the key areas for improvement. There were organisations-Seva Foundation, Orbis International- also discussions to arrive at a consensus on appropriate Bangladesh, ChildSight Foundation Global-Bangladesh, mentoring approaches that will effectively address the and IAPB-South East Asia to conduct a Rapid needs of the partner hospitals. Assessment of Refractive Error (RARE) survey in Forcibly Displaced Myanmar Nationals (Rohingya Fostering improvements for excellence in care Refugees) residing in camps at Cox\u2019s Bazar, Bangladesh. Based on the requirements from the study team in LAICO 12-13 October 2022 Bangladesh, LAICO\u2019s research team developed the Advancements in science and technology, and ever- study database and digital data collection process increasing expectations of patients create extensive using tablets. As the data was being collected data opportunities for eye care providers to continuously management and data analysis was carried out. improve their systems and processes. In the process, they face several operational challenges which can The department conducted a Research Methodology be addressed through a scientific approach. Hence Workshop for the ophthalmology residents of SEH, workshop introduced improvement methodologies Sitapur, Uttar Pradesh on 21st and 22nd February. Ten and tools that hospitals would find useful to address residents took part. The workshop covered topics such operational problems and bring improvements in care as literature review, sample size calculations, statistical delivery. A total of 28 participants from 17 hospitals in analysis and points to keep in mind while preparing the India and Africa took part. thesis. To build research culture at LAICO, the Research Division organises weekly journal clubs attended Workshop on operational excellence by Aravind employees and members from LAICO\u2019s partnering institutions, both national and international. LAICO, 17-20 October 2022 49 journal club sessions were held in the past year, of The internal workshop focused on topics such as which 12 were handled by external participants. retaining Aravind\u2019s work culture, managing quality, patient care management, monitoring, materials The Research Division organised WRITATHON 1.0 management, insurance facilitation and how to become on 28th and 29th January which was a culmination of an effective manager. its weekly research enhancement activity conducted every Saturday for LAICO faculty. As a result of the A total of 63 managers and senior MLOP across all initiative, two papers got published in peer reviewed branches of Aravind Eye Hospital participated. The journals and other manuscripts are in different stages of workshop started with a performance update by the completion. individual hospital teams. Group discussions were held on common issues such as hospital-acquired infections, The department has also initiated three \u2018Systematic patient safety, and arrival patterns. An exhibition of the Review and Meta-Analysis\u2019. The first study investigated calendars of various departments, proud moments, and the accuracy and agreement of Transpalpebral various innovations were displayed. tonometry with Goldmann applanation tonometry. The next review scrutinised the diagnostic accuracy of AI in diabetic retinopathy screening in real world settings, and the third meta-analysis will compute the prevalence of glaucoma in India. The manuscripts are getting ready to be published. 58","In an effort to enhance research activities involving both clinicians and scientists, regional research centres have been established at Tirunelveli, Pondicherry and Coimbatore. These centres have already initiated several major research programmes. Another major initiative of AMRF, the Exosome Innovation Centre is now fully functional, and has already attracted users from other organisations. The multi-centric study to identify the biomarkers for the prediction of the progression of diabetes to diabetic retinopathy has been completed and published in JAMA. Research 59","Molecular Genetics patients implies that RB is not passed on to the next generation. The current focus of research is to develop in-vitro models of Leber\u2019s hereditary optic neuropathy (LHON) Tumour samples of five patients without any RB1 and Leber\u2019s congenital amaurosis (LCA) using siRNA- mutations were analysed for altered transcripts and mediated genetic knockdown and site-directed identified two variants causing distinct splicing mutagenesis, respectively in order to investigate the alterations leading to intron retention and exon candidate genes that influence disease progression. skipping. Three tumours showed no RB1 gene In LHON, this study utilised mouse 661W cells as expression. Gene amplifications of receptor tyrosine precursors for retinal ganglion cells (RGCs), which kinase found in RB tumours suggested them as potential might represent an ideal model to study the molecular drug targets. Focused PCR array approach identified mechanisms that cause RGC degeneration. In LCA, alterations of six key genes involved in multiple cancer GUCY2D gene tightly regulates cGMP expression pathways. of photoreceptors. Site-directed mutagenesis was performed to determine the functional consequences RB is also influenced by epigenetic alterations of GUCY2D mutants. Thus, the in-vitro model helps as evident from the differential expression of 246 understand the effect of GUCY2D missense mutations microRNAs and their 80 target genes. Newer drugs in the function of photoreceptor degeneration. were developed against specific molecular targets in cell culture systems which might help combat Genetics of ocular tumours chemoresistance in RB. In tumours with invasions and metastasis to central nervous system, GD2 synthase During the year, 58 retinoblastoma (RB) patients was found to be higher, which can be used as a potential including 12 follow-up patients were checked for marker for RB tumour spread into other systems. their genetic status of RB1 gene. Germline and somatic mutations were identified in 22 and 4 patients Ocular adnexal lymphoma is the most frequent respectively. Appropriate genetic counselling was orbital neoplasm found in 8\u201310% of all extranodal provided for families based on the mutation pattern. lymphomas. The clinical characteristics and their Absence of the germline mutations in the remaining 32 effect on survival and outcome were reviewed in ocular adnexal lymphoma patients, presented during 2012 to Nucleic acid extraction using Vacuum manifold 2019. Disease specific survival was found to be better in patients less than 55 years of age. Proteomics Diabetic retinopathy project Extracellular vesicles (EVs) are lipid-bilayered non- dividing nano-vesicles that carry physiology-altering biological information in the form of regulatory nucleic acid, protein, lipids and metabolites. While their role in cancer angiogenesis is being widely established, their contribution in diabetic retinopathy (DR) pathogenesis is largely unexplored. The team has used ultracentrifugation, nanoparticle tracking analysis\/ transmission electron microscopy\/immunoblotting to isolate and characterise EVs from plasma and vitreous humour from patients with proliferative DR. Using proteomics approach, the team has identified and shortlisted EV proteins that are unique\/enriched in either plasma or vitreous humour of PDR patients. This study is a stepping stone to understanding what vitreous humour (VH) EV proteins are represented in circulation and thus can be used as EV-based biomarker candidates. 60","Pterygium project Ocular Pharmacology Pterygium is a highly prevalent, conjunctival eye disease There exists differential steroid responsiveness that has a significant impact on quality of life and in patients on long-term steroid therapy for any causes vision impairment, mostly affecting people with inflammatory eye diseases which limit the usage low socioeconomic status working outdoors. While of steroids in a clinical set up. Therefore, the team altered epigenetic modifications by chronic sunlight has undertaken a study to investigate the role of exposure plays a pivotal role in skin cancer, the role of miRNA in the regulation of glucocorticoid receptor epigenetic changes in pterygium pathogenesis is not (GR) signalling and to develop new miRNA-based explored although UV exposure is a causative factor. therapeutics for the treatment of steroid-induced The team proposes to test this using genome-wide DNA glaucoma. methylation profiling, transcriptomics and proteomics approach. Using proteomics and transcriptomics In order to achieve this, an ex vivo model of steroid- approach, the team has identified and shortlisted targets induced ocular hypertension was established using in angiogenic, fibrotic, and inflammatory pathways human organ culture anterior segment (HOCAS) and altered in pterygium. These candidates will be targeted assessed the differential glucocorticoid responsiveness using small molecule inhibitors in a fibroblast cell- in Indian donor eyes. Followed by this, human culture model. trabecular meshwork cells (HTM) with known glucocorticoid (GC) responsiveness was established Keratoconus project to investigate the differential expression of mRNAs and miRNAs between GC-responder and non- The team has investigated the mechanism of action responder HTM cells after Dexamethasone treatment. of a novel chemical cross-linker for the treatment of Interestingly, this study revealed a distinct gene and keratoconus. Experiments to study the mechanism of miRNA signatures and pathways identified between action revealed that the novel cross-linker regulates them using next generation sequencing technology. genes related to extracellular matrix (ECM), focal Further, in order to demonstrate the role of miRNA in adhesion, and WNT signalling pathways in the corneal SI-OHT\/glaucoma, the hsa-miR-483-3p has been chosen epithelium. In corneal stroma, ECM, metalloprotease, from the differentially expressed miRNAs. It was found collagen synthesis and TGF\u03b2 signalling pathways are that the hsa-miR483-3p was found to regulate ECM affected coupled with the reduction in inflammatory proteins through smad4\/TGF-\u03b22 signalling, more genes. The cross-linker could reduce the inflammatory pronounced in GC-R as compared to GC-NR HTM conditions associated with keratoconus. Matrix cells. Further, the efficacy of miR483-3p in an ex vivo metalloprotease (MMP-2 and 9) analysis by gelatin model of SI-OHT has been demonstrated. The team has zymography in the corneal epithelial and stromal layers validated the findings of in-vitro miRNA functional role showed consistent decrease of MMP-2 and using HOCAS. This study also identified some other MMP-9 activity after crosslinker treatment. Cathepsin unique miRNAs and pathways which can be exploited G activity is decreased in stroma of keratoconus cornea to further develop miRNA-based therapeutics for the after corneal collagen crosslinking (CXL) treatment. management of steroid glaucoma and POAG. The CXL possibly inhibits the surge in activity of MMP-2, MMP-9, and cathepsin-G, thereby reducing Bioinformatics the degradation of matrix in keratoconus cornea. CXL also brings together the disorganised collagen The lab develops bioinformatics tools and provides fibres in stroma leading to the increase in stiffness in next-generation sequencing data analysis services for in- keratoconus corneas. The novel chemical crosslinker house research projects. VarP tool has been developed seems to be associated with inhibition of the signalling recently to predict the pathogenicity of variants pathways involving the MMP-2, and MMP-9, leading from the whole genome or exome data set, which to corneal stiffening, thereby halting the progression of outperformed all the existing tools in predicting single keratoconus disease. nucleotide variants and small insertions and deletions. eyeVarP tool has been developed to identify pathogenic variants specific to eye diseases, which also prioritise the variants with given specific patients\u2019 phenotype and inheritance pattern. In tandem, the lab had identified 61","TB-specific miRNAs as potential diagnostic markers in cells identified these nanovesicles to enhance cell aqueous humour or vitreous humour of the ocular TB proliferation and anti-oxidant potential of TM cells patients, which have been tested in the serum of the indicating the possibility of developing a nanovesicle- ocular-TB patients. A list of miRNA markers has been based therapy for TM regeneration in patients with identified that predict the disease severity in fungal primary open angle glaucoma. Studies are being carried keratitis. out to identify the molecular regulation of human trabecular meshwork stem cells and retinal pigment Stem Cell Biology epithelial stem cells. Adult stem cells present in almost every tissue of Infrastructure development the body are responsible for maintaining the tissue homeostasis throughout life. The focus of research in Exosome innovation centre this department is to understand the basic biology of the adult ocular stem cells, changes in the content\/ Extracellular vesicles (EVs) or exosomes (small EVs) function of these stem cells with ageing and in are lipid-encased nanoparticles that carry information diseased condition, and to develop better stem cell from parent cells in the form of DNA, RNA, protein, based therapy for ocular diseases. Studies are being lipids and metabolites and can alter the cellular carried out on limbal epithelial stem cells in relation physiology of local cells or distal cells by travelling to limbal stem cell deficiency, trabecular meshwork through peripheral blood. The involvement of EVs in stem cells in glaucoma, lens epithelial stem cells in several (patho) physiological processes along with age-related cataract, and retinal pigment epithelial stem their molecular composition reflecting the parent cell cells in age-related macular degeneration. in health and disease state, makes EVs an excellent tool for diagnostic biomarkers and understanding their The major highlights of the research carried out role in disease pathogenesis. AMRF has established a this year include identification of the stem cells for state-of-the-art facility to facilitate exosome research human retinal pigment epithelium to be located in the in ocular and other related areas. This facility is a part peripheral region based on the functional properties of the translational initiative for the basic research of adult stem cells. In addition, an age-related programmes at AMRF. It includes the infrastructure reduction in the functional properties of the retinal and equipment for carrying out end-to-end workflow pigment epithelial stem cells as well as lens epithelial right from isolation, confirmation, and characterisation stem cells has been established. Recent research on of exosomes. exosomes from the trabecular meshwork (TM) stem Exosome innovation centre at AMRF 62","Dr. P. Namperumalsamy inaugurating the regional research centre at Aravind-Coimbatore Regional research centres Seminar on biomedical applications of fundamental research and future potential To strengthen and expand the scope of research, regional research centres were established at Aravind- 14th October 2022 Tirunelveli, Coimbatore, and Pondicherry. These centres As part of October Summit 2022, AMRF organised the are equipped with adequate infrastructural facilities seminar to familiarise the teaching faculty from various to initiate research programmes in collaboration with colleges on the research programmes and various AMRF. Plans are underway to establish a similar centre facilities at Aravind. The aim was to motivate them to at Aravind-Chennai. encourage their students to take up research. A total of 22 teachers from colleges in and around Madurai Conferences \/ Workshops conducted attended the seminar. Training programme on tissue culture techniques AMRF - Dartmouth education and research conference 3rd September 2022\t The Department of Immunology and Stem Cell Biology 29-30 November 2022 conducted the one day training as part of the scientific AMRF conducted the conference in collaboration with social responsibility activity of an ongoing project Dartmouth College, Hanover, USA. Eleven students funded by Science and Engineering Research Board, from Dartmouth College presented research proposals New Delhi. A total of 10 Ph.D scholars from surrounding on various eye diseases. Research works carried out colleges and universities took part. The programme included invited talks and laboratory sessions. College teachers at the seminar on biomedical applications of fundamental research and future potential 63","AMRF - Dartmouth education and research conference at AMRF were presented as posters by the research Ongoing projects scholars. Details of core research facilities and ongoing research projects were presented by AMRF scientists to Basic research the Dartmouth team. -\t Molecular regulators associated with the maintenance of human Workshop on basics of tissue culture trabecular meshwork stem cells in relation to their reduction in aging and glaucoma 7-11 February 2023 The five-day workshop included a series of lectures and -\t Molecular characterisation of human retinal pigment epithelial laboratory sessions to give hands-on training on tissue stem cells and their role in age related macular degeneration culture techniques. It had 16 participants including faculty, research scholars and postgraduates from -\t Identification and characterisation of adult human retinal surrounding colleges and universities in Madurai. pigment epithelial stem cells -\t Adult stem cell derived extracellular vesicular miRNAs for trabecular meshwork regeneration in glaucoma -\t Characterisation of adult human lens epithelial stem cells in the maintenance of tissue homeostasis throughout life and their functional status in cataractous lens -\t Deciphering predictive and preventive methods in the progression of pterygium using multi-omics approaches Participants of the workshop on basics of tissue culture with AMRF team 64","PhD Awarded by Alagappa University Aloysius Abraham K. Lavanya A. Divya Department of Molecular Genetics Department of Immunology and Department of Proteomics Thesis: Interaction of Thesis: Identification of modifier Stem Cell Biology genes involved in tumorigenesis of Thesis: Micro RNAs specific to pathogenic fungi with human corneal epithelial cells retinoblastoma corneal epithelial stem cells Guide: Dr. A. Vanniarajan Guide: Dr. Gowri Priya Guide: Prof. K. Dharmalingam Chidambaranathan -\t Screening the Kadaladi family with early onset glaucoma for -\t Investigating the role of extracellular vesicles in pathogenesis of Myocilin gene mutations diabetic retinopathy -\t Whole genome sequence analysis of selected family members of -\t Proteomic analysis of vitreous humour extracellular vesicles in the Kadaladi family and identification of markers for the early patients with proliferative diabetic retinopathy detection of JOAG using tear extracellular vesicles -\t Role of trabecular meshwork stem cell-derived extracellular -\t Surfaceome profile of extracellular vesicles vesicular miRNAs in human trabecular meshwork regeneration -\t Development and validation of a non-invasive point-of-care -\t Molecular characterisation of Leber\u2019s congenital amaurosis in diagnostic tool for fungal keratitis South Indian cohort -\t Mechanotransduction in retinal pigmented epithelium -\t Investigating the crosstalk between nuclear and mitochondrial homeostasis and degeneration: Implications in age-related genome in patients with Leber\u2019s hereditary optic neuropathy macular degeneration -\t Molecular genetics of juvenile X-linked rtinoschisis in South -\t Role of dietary fatty acids in the progression of diabetic Indian population retinopathy -\t Expression profiling of human corneal miRNAs and their role in -\t Role of human corneal miRNAs in the onset and severity of fungal Pseudomonas aeruginosa induced keratitis keratitis -\t Identification and analysis of alternative transcripts in -\t Understanding the mechanism of action of a novel chemical cross- retinoblastoma progression linker designed to treat keratoconus -\t Identification of dysregulated MicroRNAs in ocular fluids as -\t Translational genomics of ocular cancers diagnostic markers for intraocular tuberculosis\t -\t Targeted modulation of E2F3 and KIF14 pathway in -\t Identification of host immune factors as predictor of severe retinoblastoma refractory to existing chemotherapeutic drugs human fungal keratitis and their utility in disease management -\t Molecular characterisation of tumor progression in -\t Modelling macular degeneration using human pluripotent stem retinoblastoma cells for better understanding of disease pathophysiology and to investigate novel therapies -\t Molecular characterisation of ocular lymphoma for improved disease prognosis Clinical research -\t Role of miRNA in the regulation of lucocorticoid receptor Glaucoma signalling and development of new therapeutics for steroid- induced glaucoma -\t Screening the Kadaladi family with early onset glaucoma for Myocilin gene mutations and development of ER stress reversing -\t Identification of druggable targets for attenuating the progression novel chemical entities as topical ophthalmic formulations of pterygium development -\t A prospective, randomised, comparative study of efficacy and -\t Deciphering the role of extracellular vesicles in the modulation of safety of subtenon injectable 20\u00b5g Mmc Vs 40\u00b5g Mmc in host immune response in fungal keratitis patients trabeculectomy patients -\t Proteomic and metabolic analysis of microbial keratitis patient\u2019s tear to identify biomarkers of corneal microbial ulcer progression 65","-\t A comparative analysis of non-absorbable 10-0 nylon sutures -\t Comparing outcomes of femto laser assisted cataract surgery with absorbable 10-0 Vicryl sutures in phaco-trabeculectomy to conventional phacoemulsification in nanophthalmos eyes - A surgery randomised controlled trial -\t A comparison of viscoat augmented delivery of injection -\t Structural and functional correlation in nanophthalmic eyes mitomycin-C and conventional subconjunctival injection of Mitomycin C in phacotrabeculectomy -\t Factors affecting follow-up adherence of glaucoma patients -\t Randomised control trial: Once daily Netarsudil Vs twice daily -\t An analysis of re-surgeries following primary glaucoma surgical Timolol in patients with elevated intraocular pressure interventions -\t Surgical outcome of Tanito microhook ab interno trabeculotomy -\t Long term surgical outcomes of glaucoma associated with Sturge with phacoemulsification Vs gonioscopy-assisted transluminal Weber syndrome in Children trabeculotomy with phacoemulsification in patients with mild to moderate open angle glaucoma: A randomised comparative study -\t Factors affecting diabetic retinopathy patients\u2019 adherence to at a tertiary eye care centre scheduled follow-up -\t To assess the safety and efficacy of combined phacoemulsification -\t Role of miRNA in the regulation of glucocorticoid receptor trabeculectomy Vs phacoemulsification- non penetrating deep signalling and development of new therapeutics for steroid- sclerostomy in advanced glaucoma - A randomised control study induced glaucoma at a tertiary care centre -\t Real world data collection of VISULAS green selective laser -\t To evaluate the efficacy and safety of Aurolab aqueous drainage trabeculoplasty in routine office \/ hospital use implant on intraocular pressure reduction in paediatric patients with refractory glaucoma Cataract -\t Asia primary tube versus trab study -\t To compare the effect of existing hydrophilic intraocular lens and newly designed hydrophilic intraocular lens over posterior -\t Shared medical appointments randomised trial capsule opacification rates in cataract patients -\t Enhancing early glaucoma detection through family screening to -\t To assess the safety and efficacy of posterior chamber phakic reduce glaucoma related blindness intraocular lens in patients with high myopia -\t Screening of juvenile open angle glaucoma patients and their -\t Comparative analysis of single dose intraoperative sub- family members for myocilin gene mutations conjunctival depot steroid to routine topical steroids and NSAIDS in phacoemulsification -\t Evaluation of the accuracy of an automated algorithm for glaucoma detection from colour fundus photographs taken on -\t The natural history of IOL in eyes with exfoliation syndrome a low-cost camera as compared with the gold standard clinical evaluation - A prospective study -\t Visual performance comparison between phacoemulsification and manual small incision cataract surgery in eyes with senile -\t Safety and stability of topical Latanoprost eye drops: A cataract: A prospective randomised clinical trial randomised prospective observational study -\t Comparative analysis of simulator-based training and -\t Non-inferiority of Nanodropper-mediated microdrops vs. traditional wetlab training on the cataract surgical outcome in standard drops of 0.5% timolol maleate in patients with open- manual small incision cataract surgery: A prospective study angle glaucoma or ocular hypertension -\t Validation of cataract detection tool: An artificial intelligence -\t Smart phone drop reminder app and smart box based app on android mobile -\t Family \u2013 primary glaucoma evaluation study -\t Effect of Nd: YAG laser posterior capsulotomy on higher order aberrations -\t Improving adherence to follow-up in childhood glaucoma -\t Characterisation of adult human lens epithelial stem cells in -\t Family screening of glaucoma the maintenance of tissue homeostasis throughout life and their functional status in cataractous lens -\t An open label, multicentric, phase III, prospective study to evaluate the efficacy, safety and tolerability of triple fixed dose -\t To study the safety and performance of high refractive index cast combination of Timolol 0.5% + Brimonidine 0.2% + Brinzolamide molded hydrophobic intra ocular lenses with age-related cataract 1% eye drops in patients with open angle glaucoma\/ocular patients hypertension not responding to dual drug therapy -\t Effect of preloaded capsular tension ring on clinical outcomes -\t A randomised, multicentric, active controlled, parallel-group during and after phacoemulsification cataract surgery study to access efficacy and safety of fixed dose combination of Netarsudil and Latanoprost ophthalmic solution (0.02%w\/v + -\t A prospective, randomised, double blind, comparative study to 0.005% w\/v) in comparison with Latanoprost eye drops (0.005% evaluate the surgical performance of Nanocut and Aurolab round w\/v) in patients with open angle glaucoma or ocular hypertension stock surgical blades for making corneal incisions during cataract surgery. -\t A comparison of the efficacy and cardiovascular adverse events between conventional, commercial 0.5% Timolol maleate and 10 -\t Detection of posterior capsule integrity in posterior polar \u00b5L drops of 0.5% Timolol maleate using a nanodropper adaptor in cataract during pre-operative biometry using IOL master 700 adults with primary open-angle glaucoma or ocular hypertension -\t Comparing outcomes of femto laser assisted cataract surgery to conventional phacoemulsification in nanophthalmos eyes- A randomised controlled trial 66","Cornea -\t Bynocs Vs patching combined squint +IOL in paediatric population -\t Steroids and cross-linking for ulcer treatment -\t Screening, diagnosis, and treatment of keratoconus in Down\u2019s -\t Surgical outcome of Helveston syndrome syndrome patients from South India- A prospective study -\t Outcome of cataract surgery in children with congenital -\t To assess the safety and efficacy of posterior chamber phakic glaucoma having Aurolab aqueous drainage implant intraocular lens in patients with high myopia -\t Surgical outcomes of superior oblique tuck as a single surgery for -\t A prospective study of postoperative astigmatism in 1 year post acquired superior oblique palsy \u2013 A retrospective analysis penetrating keratoplasty patients in a tertiary care hospital in -\t Adjustable strabismus surgery in children under general south India anaesthesia -A retrospective observational study -\t PCR based detection and identification of Microsporidia (Coarse SPK) and its species from patients with keratitis -\t Unilateral resect recess for near distance disparity in convergence -\t Standard Vs novel medication form based counselling for corneal insufficiency exotropia ulcer -\t Automated quantitative ulcer analysis study -\t ERG in nanophthalmos -\t Rose Bengal electromagnetic activation with green light for infection reduction study Retina -\t Seasonal conjunctivitis outbreak reporting for prevention and improved outcomes -\t Efficacy and impact of artificial intelligence based retinal -\t Epidemiology and rapid diagnosis of fungal keratitis in India: A screening at rural primary eye care centres in southern India multicentric approach -\t Identification of druggable targets for attenuating the progression -\t Subjective high-risk patient counselling randomisation project of pterygium development -\t Role of human corneal MiRNAs in the onset and severity of -\t Genetic characterisation of macular telangiectasia (MacTel) 2 in fungal keratitis the Indian population -\t Prediction of the identity of the fungal pathogen (Fusarium vs A. flavus) using tear protein as diagnostic markers -\t A study on the differential expression of Piwi-interacting -\t Role of extracellular vesicles in the modulation of host immune RNAs(piRNAs) and altered Piwi-like protein interactions in response in fungal keratitis diabetic retinopathy -\t Diagnostic accuracy of smartphones for photographing corneal scars -\t A double masked, parallel group, randomised, multicentre, clinical study to compare efficacy and safety of Intas Paediatric Ophthalmology Ranibizumab with Lucentis\u00ae in patients with neovascular (wet) age-related macular degeneration -\t A multi-centric, randomised, controlled trial to compare the efficacy of 0.01 Vs 0.05% atropine in progression of myopia in the -\t Clinical profile and multimodal imaging characteristics of Indian population macular telangiectasia type 2 in Indian population -\t Assessment of parental awareness about paediatric visual -\t Validation of an offline artificial intelligence system integrated problems by a knowledge-attitude-practice (KAP) survey on a smartphone fundus camera for age-related macular degeneration screening -\t Correlation of refractive error in siblings of paediatric patients attending a tertiary level eye hospital -\t An extension study to evaluate the long term efficacy and safety of Ranibizumab compared with laser therapy for the treatment of -\t Identification of potential barriers to timely access to sibling eye infants born prematurely with retinopathy of prematurity check up -\t Structured post-marketing surveillance to collect the safety data -\t Effect of combined Atropine and patching Vs patching alone for of intravitreal Aflibercept injection in patients with wet age- treatment of severe amblyopia in children aged 3 to 12 years related macular degeneration during real world clinical practice -\t Augmented loop Myopexy with IOL in heavy eye syndrome -\t Improving retinopathy of prematurity telemedicine systems in -\t Role of LDA in myopic progression in Indian population south India -\t Filamentary keratitis post strabismus -\t Other eye surgery in patients with traumatic 3rd nerve palsy -\t Long-term effects of semaglutide on diabetic retinopathy in -\t Unique case of isolated superior oblique Palsy subjects with type 2 diabetes -\t Acute onset esotropia post lockdown -\t Optic nerve glioma in children -\t A phase III, comparative, double blind, randomised, multi centre -\t Motility asssessment in glaucoma drainage devices study to compare the efficacy, safety and immunogenicity of Sun\u2019s -\t Profile of secondary IOL in paediatric patients: A retrospective Ranibizumab with reference biologic in patients with neovascular age-related macular degeneration study -\t A randomised, phase 3, double-masked, parallel group, multicentre study to compare efficacy and safety of QL1205 versus Lucentis in subjects with neovascular age-related macular degeneration -\t A multicentric, extension study to evaluate the safety and efficacy of MYL-1701P in subjects with diabetic macular edema completed MYL-1701P-3001 67","-\t A randomised, active-controlled, double-masked, parallel- -\t A phase 3, randomised, double-blind parallel group, multicentre group, phase 3 study to compare efficacy and safety of CT-P42 in study to compare efficacy, safety, pharmacokinetics, and comparison with Eylea in patients with diabetic macular edema immunogenicity of BP05 Versus EU- Approved Lucentis\u00ae in patients with wet (neovascular) age-related macular -\t Accuracy of smart phone based mydriatic fundus camera in the degeneration. detection of CMV retinitis -\t A randomised, double-masked, parallel-group, multicenter -\t A prospective study for ocular and systemic pathologies clinical study to evaluate the efficacy and safety of AVT06 Compared with EU-Eylea\u00ae in subjects with neovascular (wet) -\t Evaluation of topical Hydroxypropyl methylcellulose in reducing age-related macular degeneration the post intravitreal injection discomfort through a questionnaire -\t A phase III, prospective, randomised, parallel group, double- -\t A pilot study to understand the impact of Zydus Cadila\u2019s blind, multicentre study to compare the efficacy, safety, and Bevacizumab with Roche\u2019s Bevacizumab in patients with retinal immunogenicity of Lupin\u2019s Aflibercept with Eylea\u00ae in patients pathology with neovascular age-related macular degeneration -\t A comparative study to determine the impact of an altered patient Orbit and Oculoplasty flow using fundus imaging in the general OPD of a tertiary eye hospital in south India -\t The learning curve in external dacryocystorhinostomy: Experience of a fellowship trainee at a tertiary care centre -\t A prospective study to evaluate the early real-world evidence of Brolucizumab in patients with polypoidal choroidal vasculopathy -\t Translational genomics of ocular cancers -\t Knowledge, attitude and practice (KAP) Questionnaire study on General Ophthalmology retinopathy of prematurity among ophthalmologists in a tertiary care hospital -\t Remote mobile phone app for diagnosis of anterior segment disease - a new model for community based screening -\t Laser for retinopathy of prematurity under subtenon anesthesia - A randomised control study Uvea -\t A randomised clinical trial to determine the impact of an altered -\t Diagnostic markers for ocular tuberculosis patient flow using fundus imaging in the general OPD of a -\t A phase III, multicentre, sham-controlled, randomised, double- tertiary eye hospital in south India masked study assessing the efficacy and safety of intravitreal -\t Anatomical outcomes of posterior sclerostomy with and without injections of 440 \u00b5g DE-109 for the treatment of active, non- Mitomycin C in nanophthalmos with uveal effusion syndrome infectious uveitis of the posterior segment of the eye -\t Combined pars plana vitrectomy with inferior endolaser ablation Neuro-ophthalmology of pars plana in neo-vascular glaucoma -\t Role of microperimetry in toxic neuropathy and optic neuritis- A -\t Comparative analysis of the outcome of large macular holes cross sectional study operated with platelet rich plasma derived nanovesicles versus platelet rich plasma -\t Demographic profile and ophthalmic manifestations of ocular myasthenia- A hospital based retrospective study -\t Establishment of Aravind registry for inherited diseases of the eye -\t Neuro ophthalmic manifestations of tuberculosis -\t Intraocular lens type and retinal oxidative stress -\t Neuro ophthalmic manifestations in thyroid disorder- A five year -\t A pilot study to assess the efficacy of oral Lamivudine for macular retrospective study edema due to retinal vein occlusions Health Systems Research -\t Deep Learning-based automated macular fluid quantification and predictive analytics for patients with BRVO -\t Impact of electronic medical record implementation on provider and patient satisfaction -\t Intravitreal Triamcinolone acetonide for macular edema in hypertensive retinopathy -\t Global estimation of cataract surgeries -\t Causes and visual outcomes of ocular injuries among patients -\t Clinical features, management and outcome of diabetic retinopathy complicated by chronic myeloid leukemia visiting primary eye care centres in south India -\t Prevalence of glaucoma in India - A systematic review and meta- -\t Intravitreal Dexamethasone implant (Ozurdex) combined with vitrectomy for diabetic macular edema analysis -\t Evaluation of the accuracy and reliability of transpalpebral -\t Clinical profile, microbiological study, and follow up of scleral buckle removal - 12 years of experience from a tertiary eye centre tonometers compared with Goldmann Applanation Tonometer \u2013 A systematic review and meta-analysis -\t Factors affecting diabetic retinopathy patients\u2019 adherence to -\t A prospective, observational study to determine the impact of an scheduled follow-up altered patient flow using fundus imaging in the general OPD of a tertiary eye hospital in south India -\t A prospective comparative study of Lutein and Zeaxanthin -\t Impact of community-based eye health education programme on adjunctive therapy with pars plana vitrectomy in macula of service uptake and speciality diagnoses in vision centres rhegmatogenous retinal detachment -\t A 96-week, two-arm, randomised, single-masked, multicentre, phase III study assessing the efficacy and safety of Brolucizumab 6 mg compared to panretinal photocoagulation laser in patients with proliferative diabetic retinopathy 68","The year saw Aurolab launching new products, promising uncompromised vision for patients. A new division was opened for spectacles to address the massive and increasing problem of refractive errors. Various developmental initiatives were introduced towards ensuring maximum productivity, high quality of products as well as safety of employees. Aurolab expanded its reach with various products entering new international markets. Ophthalmic Supplies and Equipment 69","New products Aurovue Vivid continuous focus vision IOL At the launch of spectacles unit in Aurolab Aurolab launched its most technologically advanced Ribolink product, Aurovue Vivid \u2013 Continuous Focus Vision IOL, in June 2022, during the annual conference of All India Ribolink ophthalmic solution is a sterile and single- Ophthalmological Society. This product, a combination dose formula for corneal cross-linking procedures. of refractive and diffractive optics, provides smoother It is instilled in the eye during irradiation of UV-A transition in resolution between near, intermediate, light as part of the para-surgical procedure of corneal and far distances \u2013 covering from functional near collagen cross-linking. The principal objective of vision (40 cm) to distance vision (4m and beyond) riboflavin ophthalmic solution is to provide a barrier without perceptible visual disturbances. This design against UV-A penetration beneath the corneal stroma significantly improves the quality of vision and quality to protect the delicate internal structures of the eye, of life post-cataract surgery. Aurovue Vivid is built on such as the corneal endothelium, lens, and retina. the trusted Aurovue hydrophobic platform, with over 15 The administration of Riboflavin in association with years of unblemished track record and over 1.5 million UV-A light retards the progression of keratoconus and implantations globally. prevents the necessity of a corneal transplant. New initiatives and developments Ribolink On-line data collection Aurovue Vivid continuous focus vision IOL Aurolab installed an IoT based software system in a few select lathes to collect the machine\u2019s critical information such as production time, breakdown time and type of breakdown. Previously, it was done manually. This is towards Aurolab\u2019s manufacturing, eventually becoming compliant to industry 4.0 standards. Launch of optical division Refractive error remains one of the biggest causes of needless blindness. With support from Seva Foundation, USA, Aurolab opened an Optical Division on December 14 with an aim to provide premium quality spectacle lenses at an affordable rates. At present, it procures these lenses from renowned manufacturers and supplies them to hospitals. Aurolab plans to manufacture them in-house in future. 70","The event held at Aurolab to formally launch TPM across its various divisions Deployment of total productive maintenance Total Productive Maintenance (TPM), a concept originated in Japan, is a strategic method for continual improvement and excellence in all aspects of an organisation. It helps improve productivity, quality, cost, delivery, morale, safety, and the environment. Aurolab has been experimenting with this hugely successful management strategy tool for about a year and the results have been truly encouraging. A special function was organised to celebrate this success and also to deploy it across the various divisions of Aurolab formally. Deploying TPM brought immediate results in reducing energy consumption and an increase in production volume. Steps to reduce compressor energy consumption have brought down the air consumption from 3 CFM to 1 CFM in lathes, thereby resulting in considerable reduction in the noise level. This helped save about 500 units of electricity per day. Launch of TPM logo and mascot 71","Aurolab\u2019s national sales meet at Radisson Blu, Chennai. Around 130 field staff took part. Regulatory affairs show for a real-time demonstration of Hawk-i slit lamp with Third-I imaging system, targeting Management review meeting ophthalmologists in Uttar Pradesh and Tamil Nadu in August and October respectively. Operations and activities of each division in Aurolab -\t A campaign promoting hydrophobic IOLs was are streamlined through a quality management system conducted across various hospitals in Uzbekistan which involves standard audits by 50 internal quality with over 100 participants and received orders for auditors. The results of these audits are shared in the around 10,000 units. management review meeting conducted every three -\t Aurolab\u2019s sales training workshop (ASTRA) months to meet the requirements of ISO 13485 standard. for the 46 new joiners was organised at LAICO Aurolab successfully conducted the 100th management in two batches in the months of July 2022 and review meeting on 12th September 2022. February 2023. Product registration, approval, and certifications CMEs, training programmes and conferences Aurolab registered 18 products for the first time in 17 At a training programme for ophthalmologists organised countries which include Saudi Arabia, Uzbekistan, by Aravind-Chennai from 25-26 November 2022, Argentina and re-registered 26 products in 22 countries. Aurolab explained the benefits of its toric lenses for Aurocoat plus got registered in Bolivia and Peru. astigmatism correction. Aurolab has cleared Ukraine GMP Audit and registered two pharma products. CMEs and wet lab trainings were organised in Bangladesh, Egypt and Malaysia where Aurolab Aurolab has started to work with NGO organisations demonstrated its products. in the Middle East and Africa towards expanding their distribution network. Aurolab participated in major national and international trade shows and ophthalmic conferences Aurolab got approval for 13 medical devices such to create awareness of its products. as Glide and Trocar from the Central Drugs Standard Control Organisation, India. It also got 510K (FDA) Support to vision centres approval for Cornsiol, the cornea preservative used by eye banks, and this has enabled entry into the US Aurolab offers the necessary hardware, software, and market. equipment as a package to help set up vision centres. A total of 200 vision centres run by NGOs and private Marketing hospitals and institutions across the nation benefitted from this package since its launch in 2019. -\t As a first of its kind in the field of ophthalmic equipment marketing, Aurolab organised a road 72","Aurolab at various ophthalmic conferences 73","Recognitions and Achievements RECOGNITIONS Certificate of Appreciation Health Care Climate Challenge 2022 Palayamkottai, 26th January 2023 6th December 2022 Aravind - Tirunelveli received a certificate of Global Green and Healthy Hospitals, an international appreciation for exemplary performance under Chief network of hospitals dedicated to reducing their Minister\u2019s Comprehensive Health Insurance Scheme. environmental carbon footprint and promoting Dr. V. Maneksha, Chief, Orbit and Oculoplasty Clinic environmental health through its initiative \u201cHealth received the certificate from V. Vishnu, IAS District Care without Harm\u201d chose Aravind Eye Care System Collector, Tirunelveli during the Republic Day as Health Care Climate Champion 2022 among the Celebration. health care institutions in Asia. The award recognises Aravind\u2019s initiatives across the three pillars of the health Aarogyasri Award care climate challenge \u2013 mitigation, resilience and leadership \u2013 to reduce carbon footprint. Tirupati, 15th August 2022 Legendary Institution Award Madurai, 21st May 2022 Aravind \u2013 Tirupati was chosen for this award for the Rotary International District 3190 honoured Aravind best performing eye hospital under the state govt\u2019s Eye Hospital, Madurai with the award in recognition of Aarogyasri insurance scheme, for the year 2021-2022. its contributions to community ophthalmology, at the inaugural session of the Rotary National Conference on Children\u2019s Champion Award Community Ophthalmology. Tamil Nadu Medclave Honour New Delhi, 25th March 2023 Chennai, 19th November 2022 Aravind - Chennai received the Confederation of Aravind Eye Care System was honoured with the Indian Industry\u2019s Tamil Nadu Medclave Honour for Children\u2019s Champion Award by the Delhi Commission Ophthalmology. for Protection of Children\u2019s Rights, an apex body of the News18 Madurai Business Award 2022 Govt. of Delhi. The award was given in recognition of Madurai, 25th November 2022 Aravind\u2019s services to visually impaired children. Aravind - Madurai was chosen for the award in the Healthcare category. Dr. P. Vijayalakshmi, Aravind\u2019s founding member and a senior paediatric ophthalmology consultant, Aravind- Madurai who played a pivotal role in changing the face of paediatric ophthalmology in India received the award at the function held in New Delhi. Rotary Vocational Excellence Awards Madurai, 22nd April 2022 According to a study conducted by the Stanford University in the year 2021, Dr. M. Srinivasan, Director Emeritus, AECS; Dr. S.R. Rathinam, Chief, Uveitis Services, Aravind-Madurai and Dr. Lalitha Prajna, Chief Microbiologist, Aravind-Madurai were listed among the top researchers in ophthalmology. The Rotary Club of Madurai felicitated them at a special programme held at LAICO. In the consequent survey published by the Stanford University in October 2022, in addition to the three doctors mentioned above, Dr. N. Venkatesh Prajna, Director, Academics, AECS was added to the list. 74","Dr. P. Vijayalakshmi receiving the TNOA Lifetime Achievement Dr. A.P.C.V. Velayutham Memorial Oration Award Award from Manohar Devadoss Tuticorin, 17th April 2022 At the event organised by V.O. Chidambaram FICCI Healthcare Humanitarian Award Educational Society, Dr. R.D. Ravindran, Chairman, New Delhi, 11th October 2022 Aravind Eye Care System delivered the oration on Dr. P. Namperumalsamy, Chairman Emeritus, AECS Eliminating blindness in India \/ Tamil Nadu.\u2026.. Where are we now was chosen for this year\u2019s award. in our journey? AAO Secretariat Award Dr. Gullapalli N Rao Endowment Lecture Award 22nd July 2022 Mumbai, 2nd June 2022 American Academy of Ophthalmology (AAO) honoured At the 80th Annual National Conference of All India Thulasiraj Ravilla, Director-Operations, AECS with Ophthalmological Society, Dr. R.D. Ravindran delivered the Secretariat Award 2022 in appreciation of his the endowment lecture on The science of ophthalmology and contribution to the Academy and ophthalmology. my philosophy. Lifetime Achievement Award T.K. Alexander Memorial Oration Award Coimbatore, 5-7 August 2022 Dr. P. Vijayalakshmi, Senior Paediatric Ophthalmologist Kozhikode, 25th November 2022 and Chief, Low Vision Services, Aravind-Madurai Dr. R.D. Ravindran delivered the oration titled Ensuring received the Tamil Nadu Ophthalmic Association good patient experience & satisfaction in our practice at the (TNOA) Lifetime Achievement Award 2022. Annual Conference of Kerala Society of Ophthalmic Surgeons. Esteemed Positions in Ophthalmology Forums Oration Awards at the Annual Conference of -\t Dr. R. Ramakrishnan, Advisor, Aravind-Tirunelveli Andhra Pradesh Ophthalmic Society was elected as the President of TNOA for the period 2022- 2023, at its annual conference held at Vijayawada, 14th October 2022 Coimbatore from 5-7 August 2022 Dr. R. D. Ravindran delivered the Dr. P. Siva Reddy Oration on Ensuring good patient experience and satisfaction in -\t Prof. K. Dharmalingam, Director, AMRF was elected day-to-day practice. as the President of Indian Eye Research Group at its 28th annual meeting held at Hyderabad from Dr. R. Ramakrishnan delivered the Dr. Sonty Sriram 10-11 September 2022 Lecture on Drug-induced glaucoma. -\t Dr. Manju R Pillai, Medical Consultant, Glaucoma Prof. B.P. Kashyap Memorial Oration 2022 Services, Aravind-Madurai was elected Member Patna, 15th October 2022 \u2013 South Zone of the Executive Committee of the Dr. R. Kim, Chief Medical Officer, Aravind-Madurai Glaucoma Society of India in December. delivered the oration titled Unmet need in the management of diabetic retinopathy at the 35th Eastern India Zonal Ophthalmological Congress. Visiting Professorship at Wills Eye Hospital Philadelphia, Pennsylvania, 1st June 2022 Dr. N. Venkatesh Prajna, Chief, Cornea and Refractive Surgery Services, Aravind-Madurai was appointed as Visiting Professor at Wills Eye Hospital. He delivered lectures as part of the David Paton Lectureship on Aravind\u2019s training initiatives, its work on fungal keratitis and vision centres. 75","Dr. P. Namperumalsamy receiving the FICCI Dr. P. Vijayalakshmi receiving the Dr. Usha Kim receiving the News18 Healthcare Humanitarian Award from Children\u2019s Champion Award from Madurai Business Award for Aravind Smriti Irani, Union Minister of Women, Child Dr. S. Muralidhar, Chief Justice, from Thangam Thennarasu, Minister of Development of India and Minority Affairs Odisha High Court Industries, Govt. of Tamil Nadu K. Revathy and Riyah Jaitika receiving the Tamil Nadu Medclave Honour for Aravind-Chennai from M. Subramanian, Minister for Health, Govt. of Tamil Nadu Dr. R. Ramakrishnan Dr. Ashok Vardhan receiving the Arogyasri Award a\u0003 s the President of from \u0003K. Venkata Ramana Reddy IAS, District \u0003Tamil Nadu Collector, Tirupati Ophthalmic Association R. Meenakshi Sundaram \u0003receiving the Legendary Institution Award for Aravind Rotary Vocational Excellence Award for Drs. M. Srinivasan, S.R. Rathinam and Lalitha Prajna 76","Dr. R.D. Ravindran receiving the Dr. Gullapalli N. Rao Dr. N. Venkatesh Prajna after delivering the Wills Eye Paton Endowment Lecture Award from Aishwarya Rai Lecture Dr. V. P. Meera Lakshmi receiving the DNB gold medal and certificate from Dr. Bharathi Pravin Pawar, Union Minister of State for Health, Govt of India Dr. R. Venkatesh receiving the Best Doctor Award from the Lieutenant Governor of Puducherry, Dr. Tamilisai Soundararajan\u0003 in the presence of N. Rangasamy, Chief Minister, Pondicherry Amazing Woman Doctors\u2019 Day Awards for Dr. Syed Mohideen Abdul Kader, Dr. D. Chandrasekar and Award for Dr. Rodney Morris Dr. Usha Kim Aravind team with the video awards at the ASCRS 77","Amazing Woman Award Madurai, 8th March 2022 In recognition of her outstanding achievement and success in professional and social life, Dr. Usha Kim, Chief - Orbit, Oculoplasty, Ocular Oncology and Ocular Prosthetics Services was conferred the \u2018Amazing Woman Award\u2019 by the Women Empowerment forum of TN Chamber Foundation, Madurai. Best Doctor Award Dr. Renu P. Rajan receiving the L.C. Dutta Memorial Oration Pondicherry, 28th August 2022 Award Dr. R. Venkatesh, Chief Medical Officer, Aravind- Pondicherry was awarded the Best Doctor Award by the News18 TV network as part of its Sigaram2022 award ceremony. Doctors\u2019 Day Awards by the International Society of Manual Small Incision 1st July 2022 Cataract Surgeons. On the occasion of National Doctor\u2019s Day, Dr. Syed L.C. Dutta Memorial Oration Award Mohideen Abdul Kadar, Chief, Retina and Vitreous Services, Aravind-Tirunelveli was honoured for his Guwahati, 25th February 2023 exemplary contribution under the Ayushman Bharat Dr. Renu P. Rajan, Medical Consultant, Retina and Pradhan Mantri Jan Yojana scheme. V. Vishnu, IAS Vitreous Services, Aravind-Madurai received the award District Collector, Tirunelveli presented the award. organised by Chandraprabha Eye Hospital, Guwahati. IMA, Coimbatore and Coimbatore North Round Table He delivered the oration on the topic, Retinopathy of honoured Dr. Rodney J Morris, Medical Consultant, prematurity: Preventing a lifetime of needless blindness. Retina and Vitreous Services and Dr. D. Chandrasekhar, NABH Consultant, Aravind-Coimbatore for their Best Nurse Award distinguished services to the community. Tirunelveli, 12th May 2022 Rising Star Award S. Sangeetha, Aravind Community Eye Clinic, Sankarankoil was felicitated by Red Cross Society in Chandigarh, 5th November 2022 recognition of her service to the society, on the occasion of International Nurses Day. Dr. R. Sankarananthan, Medical Officer, Cataract and IOL Services, Aravind-Madurai was presented the Rising Star Award for simulation in ophthalmology Dr. R. Sankarananthan with the Rising Star Award S. Sangeetha receiving the Best Nurse Award 78","ACHIEVEMENTS Annual Conference of American Society of -\t\tDr. Prithvi Chandrakanth, Fellow, Retina and Cataract and Refractive Surgery (ASCRS) - Film Vitreous Services, Aravind-Coimbatore; Festival Awards 2022 Think under the apple tree session Washington, 22 - 26 April 2022 \t Second Prize for, Slit lamp based intraocular lens Runner-up microscope (SLIM) -\t Dr. R. Venkatesh \t Consolation prize for Smartscope Kit Category: Glaucoma Surgery \t Best free paper award in glaucoma for the paper titled, \tTitle: The lost sponge \u2013 Safe application of MMC sponges in Smartphone gonioscopy trabeculectomy \t Best poster award in comprehensive ophthalmology -\t Dr. Fredrick Mouttapa, Senior Consultant \u2013 for the paper titled, Fungal morphology identification using Paediatric Ophthalmology Services, Aravind- IOLSCOPE Pondicherry. \t He also received the International Ophthalmic Hero \tCategory: Quality in Teaching Award 2021. \tTitle: Dyes in ophthalmology -\t Dr. Hirika Gosalia, PG Resident, Aravind-Coimbatore was the First runner up in the free paper -\t Dr. Sathya Ravilla, Medical Officer, Paediatric presentation, on Neuro-ophthalmology. Ophthalmology Services, Aravind-Tirupati Title-Bruchs membrane opening minimum rim width to differentiate glaucomatous from non glaucomatous optic \t Category: Special interest atrophy. \tTitle: Are you aware of your posture when you operate? \t She was elected as the Executive Member of Young Ophthalmologists Society of India and also won the DNB Gold Medal film festival award in special category video titled New Delhi, 20th June 2022 ASPI for Residents. Dr. V.P. Meera Lakshmi, Aravind Eye Hospital, Theni -\t Dr. Maheswari, Fellow, Retina and Vitreous Services, topped the Ophthalmology speciality of the Diplomate Aravind-Coimbatore secured First prize in free of the National Board (DNB) examination at the paper presentation on Community Ophthalmology. national level. At a special function held in New Delhi, Title: Trash to treasure retcam: Treasure to save sight amidst she received the Dr. G. Venkataswamy Gold Medal pandemic Award from Dr. Bharathi Pravin Pawar, Union Minister of State for Health, Govt of India. -\t Dr. Sindhuja Murugesan, Aravind-Coimbatore became a Fellow of All India Collegium of Awards at All India Ophthalmic Conference Ophthalmology. Mumbai, 2-5 June 2022 Awards at Tamil Nadu Ophthalmic Association -\t Dr. Kirandeep Kaur, Consultant, Paediatric Conference Ophthalmology Services, Aravind-Pondicherry - Best physical poster in Neuro-ophthalmology - for her Coimbatore, 5-7 August 2022 poster titled Retrospective analysis of multiple cranial nerve palsies at a tertiary eye care hospital -\t Dr. Devendra Maheshwari, Medical Consultant, Glaucoma Services, Aravind-Tirunelveli - received -\t Dr. Kunal Madlik, Cornea Consultant, and Dr.Velayutham Best Paper Award. Dr. Shivaraj Tagare, PG Resident, Aravind- Pondicherry recived Consolation prize at the Think \tTitle: Early outcomes of a modified AB interno sulcus under the apple tree session for the video titled Low cost placement of Aurolob aqueous drainage implant tube. pterygium Burr, and Incremental innovations in operation theatre respectively. -\t Dr. A. Fathima, Medical Consultant, Paediatric Ophthalmology and Strabismus Services, Aravind- -\t Dr. Siddharth Narendran, Consultant, Cataract and Tirunelveli received Best Innovation Award. IOL Clinic, Aravind-Coimbatore - Rema Mohan Title: Fundus assessment technique \u2013 To assess fundus during Award for best paper in medical retina titled anterior segment surgeries. Mechanotransduction in retinal pigmented epithelium homeostasis: implications in age related macular degeneration -\t Dr. Tejaswi Prasad, Medical Consultant, Cornea Services, Aravind-Madurai received Best Poster Award. Title: Clinical and pathological characteristics of OSSN in south Indian population. 79","-\t Dr. D. Chandrasekhar, Consultant, Aravind- -\t S. Sangeetha, Manager, Administration, Aravind \u2013 Coimbatore received the Dr. Agarwal Award for Coimbatore - An analysis study on perception of presbyopia Excellence in Teaching among rural and urban women -\t Dr. Siddharth Narendran, Aravind-Coimbatore - CP Awards at the 28th Annual Meeting of the Indian Gupta Award for Best Paper in all categories. Eye Research Group (IERG) Title: Development of a Ultra- sensitive Crispr- Based Diagnositc Platform for Diagnosis of Fungal Keratitis. Hyderabad, 10-11 September 2022 -\t Dr. Hirika Gosalia won Captain Subramaniam Best -\t Hanith Raj Deivarajan, Project Fellow, Microbiology Video Award for the video titled ASPI for residents and lab, AMRF received Best Paper Award for the paper second prize in general quiz and ET Selvam Quiz. titled, Development and validation of a novel CRISPR\/ CAS12A based nucleic-acid detection platform for the -\t Dr. Jebinth Brayan M, Aravind-Coimbatore received diagnosis of ocular fungal infections. Dr. MN Best Paper Award in Cataract. Title: SPECIAL (Sitting Phaco Emulsificatin of Catract and -\t R. Iswarya, Senior Research Fellow, Department of Inraocular Lens Implantation). Immunology - received travel grant for her work on Trabecular meshwork stem cell derived exosomes enhance TM -\t Dr. Shafeena, Fellow, Aravind-Coimbatore - First Cell survival and proliferation. Prize in General Quiz and Second Prize in ET Selvam Quiz. Awards at the 5th World ROP Conference -\t Dr. B. Pranesh, Aravind-Coimbatore won second prize Dubai, 1-4 September 2022 in Time Saver session. -\t Dr. Prithvi Chandrakanth, Aravind-Coimbatore won -\t Dr. Rihana.A, MS Resident, Aravind-Madurai Best Video Award for the video titled, The journey of a received the Best Paper Award. Title: Vitreous vitreoretina fellow in RoP Screening amyloidosis in familial amyloid polyneuropathy -\t Dr. Puja Maitra, Aravind-Coimbatore won -\t Dr. Sathya T Ravilla, Aravind-Tirupati received second prize in Poster Podium Presentation.Title: 3rd place in Pitch Perfect Innovation session for Telemedicine- An effective approach to address emerging public Squintometer- prism holding device health problem of ROP Awards at the Annual National Conference of Winners \u2013 Prolate Quiz VISION 2020: The Right to Sight \u2013 India Chennai, 5 September 2022 Siliguri, 3-4 September 2022 -\t Dr. Yuvraj Madhav and Dr. Aditya Anand, Senior Best Paper Awards: Residents, Aravind \u2013 Pondicherry got the second Place in Prolate Puzzle \u2013 Quiz for post-graduates -\t D. Yesunesan, Senior Faculty, LAICO - Generating organised by Regional Institute of Ophthalmology, demand for, and enhancing uptake of eye care services during Chennai. and post COVID scenario Hanith Raj Deivarajan receiving the Best Paper R. Iswarya receiving the travel grant at Dr. Puja Maitra receiving the second Award the Annual Meeting of the Indian Eye prize in Poster Podium Presentation Research Group 80","Best Video Award Best Paper Award \u2013 Annual Conference of Kerala Society of Ophthalmic Surgeons Milan, Italy, 16-20 September 2022 Kozhikode, 27th November 2022 -\t Dr. Hirika Gosalia, Aravind-Coimbatore won Best Video Award for the video on Anterior segment Dr. Prithvi Chandrakanth won Padma Bhushan Dr Siva photography with intraocular lens \u2013 An innovative learning Reddy Best Paper Award for the paper titled, Smartphone tool at the European Society of Cataract and gonioscopy. Refractive Surgery Conference. Photo Contest Winner -Karnataka State CAHO Award for Innovation Ophthalmic Conference Mumbai, 24th September 2022 Hubli, 9-11 December 2022 -\t Dr. Prithvi Chandrakanth, Medical Officer, Retina Dr. Divya Shenoy, Fellow, Paediatric Ophthalmology, Services, Aravind-Coimbatore won second prize in Aravind-Madurai won second prize in photography the Innovation session for Smart phone-assisted frugal competition. retinopathy of prematurity screening at CAHOTECH 2022 organised by Consortium of Accredited Healthcare J.M Pahwa Best Free Paper Award Organisations (CAHO). Nagpur, 2-4 December 2022 Winners \u2013 Photography Contest Dr. Siddharth Narendran won the J.M Pahwa Best Cochin, 18th September 2022 Free Paper Award for the paper, Development of a novel crispr based diagnostic platform for rapid diagnosis of fungal -\t Dr. Maya T.J, Dr. Rinu George, Dr. Meera endophthalmitis at the 31st Annual Conference of Vitreo- Mohanakumar, Aravind-Coimbatore became winners Retinal Society of India. of the photography contest organised by Giridhar Eye Institute as part of its silver jubilee symposium. Winners - Second Edition of CII Puducherry Innovation Contest 2022 Winners \u2013 USI Photo Contest -\t Dr. Megha Nair, Cornea Fellow and Dr. Shivaraj Hyderabad, 14-16 October 2022 Tagare, Retina Fellow, Aravind-Pondicherry - Innovation: i \u2013 Verter -\t Dr. Radhika T and Dr. Anjana Somanath, Medical Consultants, Uvea Clinic, Aravind-Madurai won -\t Dr. Jenani, Cataract and IOL Fellow, Aravind- the first and second prizes respectively at the photo Pondicherry along with a team of students from contest organised by the Uveitis Society of India Pondicherry Technological University (USI) at its annual conference. \tInnovation: Saline reading monitor Best Free Paper Award - Maharashtra Ophthalmological Society Conference FIFA Award Winner - AIOS Midterm Conference Nasik, 14th October 2022 Patna, 6-8 January 2023 -\t Dr. Pinank Kharkande, Aravind-Coimbatore won first Dr. Apurva Nagtode, DNB Resident, Aravind- prize for the paper titled, Ethambutol optic neuropathy: Pondicherry won the FIFA Award for the best video Another conundrum at the Annual Conference of in New Technique Category. Title: The lost sponge!- Safe Maharashtra Ophthalmological Society. application of MMC sponges in Trabeculectomy! Awards at the 32nd Annual Conference of Best Scientific Paper Award \u2013 Asia Pacific Oculoplastic Association of India Academy of Ophthalmology Congress Mumbai, 11-13 November 2022 Kuala Lumpur, Malaysia, 23-26 February 2023 -\t Dr. Maneksha V, Chief \u2013 Department of Orbit and -\t Dr. Prithvi Chandrakanth, Aravind-Coimbatore Oculoplasty, Aravind Eye Hospital, Tirunelveli received the Best Scientific Paper Award at the 38th received Best Free Paper Award for Lacrimal sac Asia-Pacific Academy of Ophthalmology Congress. rhinosporidiosis: Clinical profile and a method of preoperative Title of the paper: Slit Lamp based intraocular lens diagnosis Microscope: A point of care diagnostic tool for fungal hyphae detection -\t Dr. Viji Rangarajan, Chief, Department of Orbit and Oculoplasty, Aravind \u2013 Coimbatore recieved Best Video Award on A bridge too far: A simple technique for management of extensive congenital upper eyelid colobomas 81","Top 5 Finalists \u2013 Surgical Video Competition Best Oral presentation Award Pondicherry, 13th March 2023 Madurai, 28th February - 1st March 2023 A surgical video of Dr. Swati Upadhyaya, Medical Consultant, Glaucoma Services, Aravind-Pondicherry. C. Prakash, Senior Research Fellow, Department became one among the Top 5 Finalists in the of Genetics, AMRF was given the award for his competition conducted by the American Glaucoma presentation titled, Nuclear gene implications in LHON Society. Title of the video: Gateway to safe gonioscopy- probands decodes autosomal recessive forms of inheritance at the assisted transluminal trabeculotomy. 4th International Conference on Genome Biology and 54th Annual Aqua-Terr Day held at Madurai Kamaraj University. As a fitting tribute to Aravind\u2019s founding members, Indian Journal of Ophthalmology carried special articles on them in its various issues over the past year. Dr. G. Venkataswamy was featured in the February 2022 issue, in Tales of Yore, which portrays the giants in ophthalmology who are no more. Dr. P. Namperumalsamy was featured on the cover page of IJO in May 2022, as part of its Living Legends Series in consideration of his pioneering work to elevate the status of ophthalmology In India and the world. The issue also had a guest editorial written by him. Dr. G. Natchiar and Dr. P. Vijayalakshmi were featured in Women in Ophthalmology column in the February and March 2023 issues respectively, in recognition of their immense contributions to ophthalmology as a clinician, mentor and researcher. 82","Aravind Eye Foundation Founded in 2000, the Aravind Eye Foundation and genetic testing for 81 patients and their relatives, supports the Aravind Eye Care System in its mission completely free of cost. A complete cycle of treatment to eliminate needless blindness through philanthropy, takes many months and includes diagnosis, surgery, volunteerism, and partnership. Since Aravind\u2019s core chemotherapy, radiation, and custom prosthesis \u2013 per operations are internally funded, the foundation patient cost is between $1,000 - $2,000. Often there is a prioritizes those areas where external support can be genetic component, so Aravind provides free testing to a catalyst for innovation or can scale proven programs discover whether other family members are at risk across our network of hospitals or to other countries. for cancer. Since the program was started in 2004, Foundation board members and advisors come from a 779 patient lives have been transformed. wide variety of fields, including clinical care, medical research, technology, higher education, venture One of those patients was six-month-old Fathima capital, and healthcare management. Following the who was diagnosed with retinoblastoma and advised intent of Aravind\u2019s founder, Dr. G. Venkataswamy, the for nine cycles of chemotherapy. She also had cardiac foundation strives to remove all barriers to high-quality, problems, so chemo had to be administered in the ICU compassionate care for all, regardless of ability to pay. of a nearby multi-specialty hospital, with Aravind overseeing her eye care. The cost of such complex Caring for our patients treatment would have been completely beyond the means of her family. The Ring of Hope fund took care of Patient care has long been a focus all her treatment costs. for the foundation, not only actual diagnosis and treatment, but also The foundation also started similar programs to covering the hidden costs which support treatment for corneal ulcers and ocular trauma. make it challenging for poor These conditions generally affect the poorest patients patients to receive treatment. \u2013 day labourers, fishermen, farmers \u2013 who are injured Transportation, accommodation, at work. Without immediate treatment, they can lose and medicines can become their sight and their livelihoods. So far, the foundation obstacles for completing a cycle of supported the treatment and associated costs of 1,970 chemotherapy or needed for a corneal ulcer. corneal ulcer patients, thanks to donations from the Gowri Family. A total of 117 ocular trauma patients were This past year, the Ring of Hope program saw 53 new treated with support from the Madison Community eye cancer patients, and provided 1,283 patient visits Foundation. Retinoblastoma Survivors\u2019 Meet, Aravind - Madurai 83","Reaching out Taking eye care beyond hospital walls to the people has always been a cornerstone of Aravind\u2019s philosophy. Its rural vision centers are able to provide all care for 85- 90% of the patients, including on-site eye exams, telehealth consultations, medicines, and eye glass prescriptions. Overall, Aravind Eye Foundation has funded 21 rural vision Centers since 2011; this past year, those centers handled 184,369 patient visits, provided 23,743 eye glass prescriptions, and enabled 7,669 cataract surgeries. My Life, My Pride programme - Volleyball team at Aravind Eye Hospital, Chennai, Tamil Nadu Aravind has a total of 105 rural vision centers across geographic limits around it. Sharing the Aravind Tamil Nadu, and many of the older ones need equipment model with other hospitals throughout the world is an important and growing part of the foundation\u2019s work. upgrades and building renovations to continue Currently, it is working with other eye hospitals across India, Bangladesh, and sub-Saharan Africa, supported providing high-quality, comprehensive eye care. This by multi-year grants from Conrad Hilton Foundation, Johns Hopkins Bloomberg School of Public Health, and year the foundation undertook a multi-year program to Lavelle Fund for the Blind. renovate 41 centers that are ten years or older, initially Additionally, the foundation started a multi-year pilot project, under the guidance of Aravind\u2019s Chairman supported by the Sachin Gupta Family. Emeritus, Dr. P. Namperumalsamy, to create a Center of excellence or \u201cBest Eye Care Zone\u201d in Theni District, Short-sightedness is growing around the world; Tamil Nadu. In its first year, Aravind conducted 136 screening camps to identify new cases of diabetic by 2050, more than 50% of the population will have retinopathy, refractive errors among school children and adults, retinopathy of prematurity (ROP), and myopia 10% will be legally blind. This is particularly glaucoma. It is planned that this project will serve as a model for other communities in Tamil Nadu and across challenging among school-aged kids, since so much India and other developing countries. learning happens visually. While serving others, we also need to nurture ourselves. This was the first full year of a new wellness Foundation\u2019s program \u2013 \u201cMy Life, My Pride\u201d for Aravind\u2019s Mid-level Ophthalmic Personnel. They are Aravind\u2019s nurses, school screening administrators, counsellors \u2013 more than 80% of its workforce. These young women from nearby villages, program is now 10 face both professional and personal challenges. The program has started in Chennai and Madurai with years old \u2013 it has group and individual counselling, as well as reading and fitness clubs. screened 1.3 million school children and given away 58,028 eyeglasses. The program had to be interrupted during the pandemic, but A student being screened at a school it is back in schools eye screening camp and making up for the lost time. This program is supported by Warby Parker. Building capacity and taking care of our staff When Dr. V. said that Aravind\u2019s mission was to eliminate needless blindness, he didn\u2019t put any Aravind Eye Foundation is thankful to its donors for their kindness and generosity in supporting Aravind Eye Care System\u2019s vision of eliminating needless blindness. It is ourselves we are helping. It is ourselves we are healing. - Dr. G. Venkataswamy 84","Partners in Service Aravind Eye Care System is grateful for the support of like-minded individuals and organisations in its mission to eliminate needless blindness. Their commitment has helped the organisation bring light to countless lives, making a significant impact in saving vision. For service delivery, training and - \t Tirumala Tirupati Devasthanams, Tirupati, - \t SASTRA University, Thanjavur, India more India - \t Science and Engineering Research Board, -\t Alcon Laboratories Inc, USA - \t TOMS, USA New Delhi, India -\t A.L Shah, Pondicherry, India - \t Topcon, Japan - \t Seva Foundation, USA - \t Aravind Eye Foundation, USA - \t Tulsi Chanrai Foundation, Nigeria - \t Sun Pharma, Mumbai, India -\t Bosch India Foundation, Bengaluru, India - \t University of Michigan, USA - \t Syracuse University, New York, USA - \t Carl Zeiss Meditec, Germany - \t USAID, USA - \t Tamil Nadu State Blindness Control Society, - \t CBM International, Germany - \t VISION 2020 - The Right to Sight, , New - \t Combat Blindness Foundation, USA Chennai, India - \t Conrad N. Hilton Foundation, USA Delhi, India - \t University of Edinburgh, UK -\t Dr. Shroff\u2019s Charity Eye Hospital, New - \t World Diabetes Foundation, Denmark - \t University of Melbourne, Centre for Eye - \t World Health Organization, Switzerland Delhi, India -\t XOVA: Excellence in Ophthalmology Vision Research Australia (CERA), Australia -\t Dr. Ravi Rengachari, Pondicherry, India - \t University of Notre Dame, Australia - \t Federation of Indian Chambers of Commerce Award, USA - \t University of Ulster, Northern Island, UK - \t University of Washington, USA & Industry, New Delhi, India For research - \t Velux Stiftung, Switzerland - \t Fred Hollows Foundation, Australia - \t Wilmer Eye institute, Baltimore, Maryland, - \t Indian Overseas Bank, India -\t Alagappa University, Karaikudi, India -\t India Alliance, Hyderabad, India - \t Aravind Eye Foundation, USA U.S. - \t Institute for Health care Improvement, USA - \t Arthur Asirvatham Hospital, Madurai, India - \t World Health Organization, Switzerland - \t International Agency for Prevention of - \t Bascom Palmer Eye Institute, USA - \t Zeiss India, Bangalore - \t Cognizant Foundation, Chennai, India Blindness, UK - \t Columbia University Irving Medical Center, - \t Kaushal Devendra Gupta, Pune, India - \t Lavelle Fund for the Blind, USA New York, USA -\t Lakshmi Eye Care Support Services LLP, - \t Council of Scientific and Industrial Research, Tamil Nadu, India New Delhi, India - \t Lions Clubs International Foundation, USA - \t Department of Biotechnology, New Delhi, -\t L V Prasad Eye Institute, Bhubaneswar, India India - \t Department of Science and Technology, New -\t L V Prasad Eye Institute, Hyderabad, India - \t Manohar Devadoss, Chennai, India Delhi, India -\t Mehra Eyetech Private Limited, Pondicherry, - \t Dr. Ambedkar University, Delhi, India - \t Geisel School of Medicine at Dartmouth, India -\t MIND TREE, Bengaluru, India Hanover, USA -\t Novartis, Switzerland - \t India Alliance, Hyderabad, India - \t ORBIS International, USA - \t Indian Council of Medical Research, New - \t Prof. Sachin Gupta, Cornell University, USA - \t Rotary International, USA Delhi, India -\t Rotary Club of Madras East, Chennai, India - \t John Hopkins University, USA -\t R.K Kanthimathi Nathan, Chennai, India - \t Kaiser Permanente Northern California. -\t S. Ajith Kumar, Chennai, India - \t Seva Canada Oakland, USA - \t Seva Foundation, USA - \t Kaizen Mindcare, Chennai, India - \t SHG Technologies, Bengaluru, India - \t Kellogg Eye Center, University of Michigan, -\t Shyam Prakash Gupta, Madurai, India - \t SightLife, USA USA - \t SightSavers, UK - \t Maastricht University, Netherlands, - \t State Bank of India, India - \t Madurai Kamaraj University, Madurai, - \t Standard Chartered Bank & Scope Intl., UK - \t So-Hum Foundation, USA India -\t Sohan Kanwar Mangilal Tater Charitable - \t Michigan State University, USA - \t National Eye Centre, Singapore Trust, Chennai, India - \t Proctor Foundation, University of -\t The Tamil Nadu Dr. MGR Medical California, San Francisco, USA University, Chennai, India - \t Ramakrishna Hospital, Coimbatore, India - \t Remidio Innovative Solutions, Bengaluru, India - \t Rio hospital for women and children, Madurai, India 85","ARAVIND EYE CARE SYSTEM Chairman CENTRAL FUNCTIONS Dr. R.D. Ravindran, ms, do\t RESEARCH PROJECTS Chairman Emeritus Director Dr. P. Namperumalsamy, ms, fams Director Dr. S. Aravind, ms, mba\t Directors Emeritus Dr. P. Namperumalsamy, ms, fams Dr. G. Natchiar, ms, do\t REGIONAL HR DIRECTORS Dr. M. Srinivasan, ms, do, fams OPERATIONS Madurai Region Dr. Usha Kim, do, dnb Director Coimbatore Region Thulasiraj Ravilla, mba Dr. Kalpana Narendran, do, dnb Tirunelveli Region Senior Manager Dr. S. Padmavathy, ms B.S. Ganesh Babu, m.com, ms Pondicherry & Salem Region Dr. K. Veena, do, dnb QUALITY Chennai & Tirupati Region Dr. Haripriya Aravind, ms Director Dr. R.D. Ravindran, ms, do\t CENTRAL OFFICE HR Manager Manager R. Deepa, mhm\t R. Ushalini, mba Academic Consultant Prof. J. Danrita FELLOWSHIP AND PHYSICIAN DEVELOPMENT PROGRAMME ARAVIND COMMUNICATIONS Chitra Thulasiraj, b.sc Director Manager Dr. S.R. Krishnadas, do, dnb Anuja Sanil, ma\t INFORMATION TECHNOLOGY PURCHASE & MAINTENANCE S. Jayachandran, mhm\t Director BIOSTATISTICS Dr. R. Kim, do, dnb\t M. Iswarya, m.sc. Chief Information Officer (CIO) LIBRARY & INFORMATION CENTRE Chief Librarian Saravanan Sankaran, b.tech, \t Dr. R. Kumaragurupari, m.li.sc, ph.d \t\t m.s - sb it Chief Technology Officer Srinivasulu Thayam, b.sc. (IT), mba FINANCE Director Dr. N. Venkatesh Prajna, do, dnb, \t frco ACADEMICS Director-Residency Training Dr. N. Venkatesh Prajna, do, dnb, \t frco 86","GOVERNING BODIES Aravind Eye Hospitals & Postgraduate Institute of Ophthalmology and Lions Aravind Institute of Community Ophthalmology GOVERNED BY GOVEL Trust BOARD OF TRUSTEES Trust President Dr. G. Venkataswamy Eye Research Institute Dr. P. Namperumalsamy, ms, fams GOVERNED BY Trust Secretary Dr. N. Venkatesh Prajna do, dnb, Aravind Medical Research Foundation frco BOARD OF MANAGEMENT Aurolab Members Mrs. Lalitha Srinivasan Dr. P. Namperumalsamy, ms, fams GOVERNED BY Dr. G. Natchiar, ms, do Dr. R. Kim, do, dnb Dr. G. Natchiar, ms, do Aurolab Trust Dr. S. Aravind, ms, mba Thulasiraj Ravilla, mba BOARD OF TRUSTEES Dr. Kalpana Narendran, do, dnb Dr. S.R. Krishnadas, do, dnb Dr. Usha Kim, do, dnb Dr. R. Kim, do, dnb Dr. Gutha Haripriya, ms Dr. N. Venkatesh Prajna, do, dnb, frco Dr. S. Aravind, ms, mba Trust President Thulasiraj Ravilla, mba Trust Secretary Dr. S. Aravind, ms, mba Members Dr. P. Namperumalsamy, ms, fams Dr. G. Natchiar, ms, do Dr. R. Kim, do, dnb Dr. N. Venkatesh Prajna, do, \t \t\t dnb, frco 87","Aravind Eye Hospitals & Postgraduate Institute of Ophthalmology ARAVIND-MADURAI Dr. Tejaswi Prasad P.V, do, dnb NEURO-OPHTHALMOLOGY Dr. C. Abinaya, ms SERVICES Chief Medical Officer Dr. K. Dhanya, do, dnb Dr. R. Kim, do, dnb Chief PAEDIATRIC OPHTHALMOLOGY & Dr. S. Mahesh Kumar, do, dnb RETINA-VITREOUS SERVICES ADULT STRABISMUS SERVICES Medical Consultants Chief Chief Dr. A. Kowsalya, do, dnb Dr. K. Naresh Babu, ms Dr. Shashikant Shetty, ms Dr. K.N. Jayasri, do Senior Medical Consultant Senior Medical Consultant Dr. P. Vijayalakshmi, ms, do GENERAL OPHTHALMOLOGY Dr. R. Kim, do, dnb Medical Consultants SERVICES Dr. A. Rupa, do Medical Consultants Dr. B. Sahithya, ms Chief Dr. R. Janani, ms Dr. Pamona Samson, do Dr. T.P. Vignesh, ms Dr. M. Elackiya, ms Dr. Renu P Rajan, md Dr. Nithya Sridharan, do Medical Consultants Dr. Haemoglobin, ms Dr. Leenu Jeris, do Dr. Girish V Baliga, ms GLAUCOMA SERVICES Dr. V. Balaji, ms Dr. Meri Debarma, ms Dr. Jeethu V Nair, ms Dr. S. Bhavani, ms Chief Dr. P. Praveen Kumar, ms Dr. Muthu Krishnan V, ms Dr. George Varghese Puthuran, ms Dr. Prithviraj U, do, dnb Senior Medical Consultant Medical Officers Dr. Anchitha Meenu R, ms Dr. S.R. Krishnadas, do, dnb Dr. Lakshmi Malar, ms Medical Consultants Dr. A. Jaisripriya, ms INTRAOCULAR LENS & CATARACT Dr. Manju R Pillai, do, dnb Dr. V. Keerthi Swathika, do SERVICES Dr. R. Sharmila, dnb Dr. V.P. Meeralakshmi, dnb Dr. S. Vidya, do Dr. G. Marian Hamsie, ms Chief Dr. H. Kasthuri Bai, do, dnb Dr. Deepachitra D, ms Dr. Madhu Shekhar, ms Dr. Indira Durai, dnb Dr. K. Shoba, ms Dr. Deeba Ishrath, do Dr. V. Priyanka, ms Medical Consultants Dr. A. Vijayalakshmi, ms Dr. M. Praveena, ms Dr. Aruna Pai, ms Dr. Raji Koshy Daniel, do Dr. Adit Samir Gandhi, ms Dr. R. Sankarananthan, ms Dr. R. Hemavathy, ms Dr. H.S. Bhanumathi, do, dnb UVEA SERVICES Dr. Tabassum Fathima, ms Dr. R.Senthil Prasad, ms Dr. Jalli Monica Sharon, ms Dr. Avitesh Kumar, ms Chief \/ Principal Dr. P. Nikila, ms Dr. K. Shalini, do, dnb Dr. R. Rathinam, do, dnb, ph.d, fams Dr. K. Sahana, ms Medical Consultants Dr. Varuna Abinethri L.M, ms CORNEA & REFRACTIVE SURGERY Dr. T. Radhika, dnb Dr. S. Sanjana, ms Dr. R. Vedhanayaki, do SERVICES Dr. S. Anjana, do, dnb VISION REHABILITATION CENTRE Chief ORBIT, OCULOPLASTY, Senior Medical Consultant OCULAR ONCOLOGY AND Dr. P. Vijayalakshmi, ms, do Dr. N. Venkatesh Prajna, do, dnb, \t\t OCULAR PROSTHETIC SERVICES MICROBIOLOGIST \t\t frco Chief Chief Dr. Usha Kim, do, dnb Dr. S. Lalitha Prajna, md, dnb Senior Medical Consultant Medical Consultants Dr. M. Srinivasan, ms, do, fams Dr. Meghana Tanwar, do, dnb ANAESTHETISTS Dr. Vinitha L Rashme, ms Dr. A. Ravichandar, md, da Medical Consultants Dr. D. Divya, md Dr. Manoranjan Das, dnb Dr. Ashwin B, do Dr. S. Suvitha, ms Dr. Sankalp Singh Sharma, do, dnb Dr. Prabhleen Kochar, ms Dr. Rahul Ramesh, ms Dr. Ninad Mudaraddi, ms 88","PHYSICIANS ARAVIND-THENI CORNEA & REFRACTIVE SURGERY Dr. R. Banushree, md SERVICES Dr. Naveen Meera, ms Chief Medical Officer \t Chief Dr. A.P. Arun Prakaash, md Dr. Dipankar Datta, do, dnb, mnams Dr. V. Anitha, dnb, faico Medical Consultants\t Medical Consultants NURSING Dr. D. Hema, ms Dr. Veena Patwardhan, ms Dr. P.S. Premkumar, dnb Dr . P. Mathuri, ms Nursing Superintendents Dr. T. Karthika, do Dr. Tariq Ahmed, ms B. Dhagirnisa Begum Dr. Arvin Kurian, ms R. Jeeva Dr. Rumi Das, ms PAEDIATRIC OPHTHALMOLOGY & ADULT STRABISMUS SERVICES MLOP Manpower Co-ordinator NURSING Chief\t - Central HR Nursing Superintendents \t Dr. R. Meenakshi, do, dnb S. Krishnaveni R. Seeniammal Medical Consultants\t R. Gowri Dr. A. Fathima, ms ADMINISTRATION Dr. Neelam Pawar, ms ADMINISTRATION Senior Manager-Clinical Services Manager-Vision Centre \t GLAUCOMA SERVICES R. Meenakshi Sundaram, mhm R. Balasiva, ba, msw Chief \t Transport & Public Relations Officer\t K. Kalidass, b.sc, msw Dr. Mohideen Abdul Kader, dnb S.G. Ramanathan, m.a Manager-Camp Senior Medical Consultants V. Jeyaraj, ba Dr. R. Ramakrishnan, ms, do Manager-Outreach IT & Systems Dr. Devendra Maheswari, ms P. Jeyaram, b.sc K. Saravanan, b.sc Medical Consultants Dr. R. Aarthy, ms Manager-Insurance Services & ARAVIND-TIRUNELVELI Dr. Madhavi R, dnb NABH Accreditation Co-ordinator Dr. Lopamudra Biswal, ms R. Sunytha, ma, mba, dll Advisor \t Dr. Nimrita Nagdev, ms Dr. R. Ramakrishnan, ms, do Manager-Instructional Design ORBIT, OCULOPLASTY AND Hepsiba Jawahar, ma Chief Medical Officer OCULAR ONCOLOGY SERVICES Dr. R. Meenakshi, do, dnb Chief \t Manager-Office\t Dr. V. Maneksha, ms K.S. Kandasamy, ba RETINA-VITREOUS SERVICES NEURO-OPHTHALMOLOGY Accounts Officer Chief \t SERVICES R. Rethinasabapathy, ba Dr. Syed Mohideen Abdul Khadar, Chief \t Dr. S. Padmavathy, ms Manager-Accounts\t ms R. Velumani, b.com, (aca) CONSULTANT ANAESTHETIST\t Medical Consultants Dr. Arun Muthukumar, mbbs, dnb Manager-Free Hospital Dr. P.R. Aswin, ms R. Ramesh Babu, ba, ma Dr. Shama Sharief, ms CONSULTANT PHYSICIAN\t Dr. R. Ram Sudharshan, ms Dr. M. R. Priya, mbbs Electrical Engineer N. Balakrishnan, me INTRAOCULAR LENS & CATARACT GENERAL OPHTHALMOLOGY SERVICES Manager-Electrical SERVICES Senior Medical Consultant R.V. Vishnu Kumar, dece Dr. R. Ramakrishnan, ms, do Chief\t Medical Consultants Manager - IT & Systems Dr. S. Padmavathy, ms S. Rajkumar, m.sc Dr. Shivkumar Chandrashekharan, \t Dr. V. Maneksha, ms Dr. R. Haridas, do, dnb Manager-Vision Centre \t\t\t ms G. Jhansi Sunitha, ma Medical Consultants Manager-Stores PR. Sigappi, msw Dr. M. Sherin Haroon, ms Manager-Quality & Patient Care Dr. Aditi Ghosh, ms H. Chandravadhanaa, mba Dr. Hanumanthu Sameera, ms Asst. Manager - Patient care P. Santhosha Ganesh, msw HR Manager E. Sakthi, m.com, phil Librarian Dr. R. Govidarajan, m.li.sc, ph.d 89","VISION REHABILITATION CENTRE Dr. Pooja Pramod Bhatlavande, dnb Dr. Abhipsa, dnb Dr. A. Fathima, ms Dr. Prithvi C, ms Dr. Rohan Daniel Dawalikar, ms Dr. Agrawal Kushal Umeshbhai, ms FREE HOSPITAL Dr. Sreelakshmi P, md UVEA SERVICES Dr. Diviyan Abraham, ms Dr. Suganya, ms Chief Manager\t Dr. V.K. Anuradha, md, frcs S. Balakrishnan, puc PAEDIATRIC RETINA AND OCULAR Medical Consultants ONCOLOGY SERVICES Dr. Meera Mohankumar, ms NURSING Chief Dr. Maheswari S, ms Nursing Superintendents\t Dr. Parag K Shah, dnb V. Arumugam Medical Consultants ORBIT, OCULOPLASTY AND A. S. Shanmuga Sundari Dr. S. Prema, ms OCULAR ONCOLOGY SERVICES Dr. Abhishek Das, ms Chief ADMINISTRATION Dr. Viji Rangarajan, do Manager-Office\t INTRAOCULAR LENS & CATARACT Medical Consultants P. Navaneetha Krishnan, puc SERVICES Dr. Kavitha Yuvarajan, do, dnb Manager-Administration Chief Dr. Renu Bansal, do, dnb M. Muthupandian, puc Dr. Kalpana Narendran, do, dnb Dr. Sindhuja, ms Public Relations Officer\t Medical Consultants M. Mahadevan, d.pharm Dr. S. Guhapriya, dnb NEURO-OPHTHALMOLOGY Manager-Human Resource\t Dr. S. Navaneeth Kumar, ms SERVICES R. Lakshmi, mba Chief Manager-Quality & Inpatient CORNEA & REFRACTIVE SURGERY Dr. Virna Shah, do Services\t SERVICES Medical Consultant M. Vikky Kumar, mba Chief Dr. M. Karthik Kumar, do Manager-Glaucoma Clinic\t Dr. R. Revathi, ms D. Ranitha Guna Selvi, bpt, mba Medical Consultants GENERAL OPHTHALMOLOGY Manager-IT & Systems\t Dr. Anita Raghavan, do, frcs (g) Medical Consultants P. Thiruvengadam, ma, pgdca Dr. P. Mangala, dnb Dr. Anita Mohanan, ms Manager-Projects & Outreach\t Dr. Devi Rosette, ms Dr. P. Vivekanand, do, dnb P. Hariesh Kumar, mba Dr. P. Shalini, ms Dr. S. Dhanalakshmi, do Librarian\t Dr. R. Jayanthi, ms Dr. Senthamilselvi, do E. Perumalsamy, m.lisc, m.phil Dr. A. Srinila, do PAEDIATRIC OPHTHALMOLOGY & Dr. D. Balasaraswathy, ms ARAVIND-COIMBATORE ADULT STRABISMUS SERVICES Dr. Bagavath Shalini, ms Chief Dr. Sangeetha V, do Chief Medical Officer Dr. Kalpana Narendran, do, dnb Dr. Siddharth Narendran, ms Dr. V. Narendran, do, dnb Medical Consultants Dr. Naveena R.L., do, dnb Dr. C. Sandra, do, dnb Dr. Fatima Amanath Assadi, dnb RETINA-VITREOUS SERVICES Dr. Sasikala Elizabeth, dnb Dr. Chavan Sneha, dnb Chief Dr. Amrudha Sindhu, dnb Dr. Haritha V, dnb Dr. V.R. Saravanan, do, dnb Dr. Jogitha, ms, dnb Dr. Vijayevarshcini D, dnb Senior Medical Consultant Dr. Vanathi N, dnb Dr. Rajpal Narayan Laxman, dnb Dr. V. Narendran, do, dnb Dr. Priya S, dnb Medical Consultants Dr. Jebinth Brayan, ms CITY CENTRE - ARAVIND EYE Dr. Rodney John Morris, ms HOSPITAL, COIMBATORE Dr. George Manayath, ms, frcs GLAUCOMA SERVICES Medical Consultants Dr. Palmeera D Souza, do, dnb Chief Dr. Manju Vinythera, dnb Dr. A. Ramya, md Dr. Ganesh V Raman, ms Dr. Menaka, do, dnb Dr. Prashanth A.S, ms Medical Consultants Dr. Akhila, do, dnb Dr. C. Prem Anand, ms NURSING Dr. Rohan Suresh Ninan, ms Dr. Mrunali Mohan, ms Nursing Superintendent Dr. Atul Madhavsa Gujarathi, ms Dr. Sunada Subramanian, dnb S. Radhika 90","Assistant-Nursing Superintendent Dr. R. Swathi, ms NURSING G.B. Amudha\t Dr. Naveen Nischal G, ms Nursing Superintendents\t Dr. Deepak V.N, ms R.V. Selvarani ADMINISTRATION\t Dr. Thamizhselvi D, dnb A. Subbulakshmi Manager-HR\t Dr. Sivagami N, dnb R. Umapriya, ma, ptsta Dr. Saradha R, ms ADMINISTRATION Manager-Personnel Dr. Anusha P Churi, dnb Manager-General \t R. Jebadurai, ba, pgdpm\t Dr. Sandeep P, ms P. Kanagaraj, be Manager-IT Systems Manager-Administration S. Thirunavukkarasu,m.sc (IT), PGDSD CORNEA & REFRACTIVE SURGERY P. Poobalan, b.com Manager-MRD SERVICES Deputy General Manager V. Hemalatha, m.phil Chief \t S. Subramanian, be Manager-Quality Assurance Dr. Josephine Christy, ms Manager-Human Resource \t R. Gautham Kumar, m.sc. ha Medical Consultants A. Sumathi, mba Manager- Patient Care Dr. Naveen, ms Manager-Camp \t B. Vignesh, mba Dr. Kunal Mandlik, ms A. Xavier, b.sc Manager - Accounts Dr. Kulharsh B Jaiswal, ms Manager-Transport & Security Krishnasami S. B.Sc, C.A.I.I.B Dr. Rakesh A. Betdur, ms K. Kaveri, b.a Electrical Engineer Dr. Rashmita R Manager-Maintenance \t A.M. Appusamy, d.e.e.e P. Thanapal, dce Civil Engineer PAEDIATRIC OPHTHALMOLOGY & Manager-Patient Care & Quality S. Ganapathi, d.c.e ADULT STRABISMUS SERVICES Assurance \t Librarian\t Chief \t K. Kalaivendan, mba K. Alagumani, m.li.sc, m.phil Dr. K. Veena, do, dnb Manager - Patient Care & Vision Medical Consultants \t Centre ARAVIND-PONDICHERRY Dr. Marie Fredrick Mouttappa, do, dnb K. Harikrishnan, ba Dr. Anjali Khadia, ms Manager - IT & Systems Chief Medical Officer \t Dr. Lavanya G.S., dnb M. Ashok, mca Dr. R. Venkatesh, do, dnb Manager - Stores GLAUCOMA SERVICES S. Vadivelmurugan, b.sc RETINA-VITREOUS SERVICES Chief \t Chief \t Dr. S. Kavitha, ms ARAVIND-SALEM Dr. Manavi D. Sindal, ms Medical Consultants \t Medical Consultants Dr. Swati Upadhyaya, do, dnb Chief Medical Officer Dr. Pankaja Dhoble, ms Dr. O. Annamalai, do, dnb Dr. B. Manohar Babu, ms Dr. S. Sivaranjani, ms Dr. C.R. Viswaraj, ms Dr. Nikita Sonawane, ms Dr. Usha Tejaswini S, do, ms, dnb CATARACT & UVEA SERVICES\t Dr. Shivangi Singh, dnb Dr. Krishna Chaitanya, ms Chief Dr. Vivek Chaitanya, ms Dr. B. Manohar Babu, ms Dr. Preet Kanwar Singh Sodhi, ms ORBIT, OCULOPLASTY & OCULAR Dr. Poulomi Das, MS Dr. Akshat B Kothari, ms ONCOLOGY SERVICES Dr. Suresh Mekala, do, dnb Chief RETINA-VITREOUS SERVICES Dr. Arun R, dnb Dr. R. Jayagayathri, do, dnb Medical Consultant Dr. Bharadwaj K, dnb Medical Consultant \t Dr. K. Hemalatha, ms Dr. Gururaj N Deshpande, dnb Dr. Dayakar Yadalla, ms, frcs CORNEA & REFRACTIVE SURGERY CATARACT - GENERAL NEURO-OPHTHALMOLOGY Medical Consultants OPHTHALMOLOGY SERVICES SERVICES Dr. J. Anuja, ms, Chief Chief\t Dr. Lokeshwari, ms Dr. V.R. Vivekanandan, ms Dr. A. Balraj, dnb Medical Consultants Dr. D. Balamuruganandaraj, do UVEA SERVICES Dr. Merlin Benzy, ms Chief Dr. S. Bala Murugan, ms 91","GLAUCOMA SERVICES Dr. Siva Shanmugam, do, dnb Dr. Priyanka S, ms Medical Consultants Dr. Priyanka Lamba, ms Dr. Pavithra S, ms Dr. Keerthana Soundararajan, ms Dr. Durga Naga Sushmitha Jasti, \t\t Dr. Kondepati Kavya Sesha Sri, ms CORNEA & REFRACTIVE SURGERY \t\t\t ms, fico GENERAL OPHTHALMOLOGY SERVICES SERVICES Chief ANAESTHETIST Medical Consultants Dr. K. Tiruvengada Krishnan, dnb Dr. Jacintha, dnb, da Dr. M. Lavanya, ms Medical Consultants Dr. Uma, ms Dr. M. Divya, ms PHYSICIANS Dr. Malligarjun B, ms Dr. Seema Ramakrishnan,do,dnb,fico Dr. Chetana Lingam, ms Dr. Joeimon, md, dmm MICROBIOLOGY Dr. Garima Singh, ms Medical Consultant Dr. J.P. Janish Prabhakar, mbbs, mem, \t Dr. Suneetha V, md PAEDIATRIC OPHTHALMOLOGY & ADULT STRABISMUS SERVICES \t\t\t mba ANAESTHETIST Medical Consultants Dr. Citrarasu M, da anes Dr. Ankita Bisani, do, dnb, fico Dr. Manoprakash Manoharan. mbss Dr. Saranya, do, dnb NURSING SUPERINTENDENT Dr. Akila C, ms ADMINISTRATION V.S. Ramya Dr. Janani, dnb Manager-Administration ADMINISTRATION GLAUCOMA SERVICES Revathy Kannadhasan, bba, mba Manager-Patient Care Medical Consultants I. Seran, mba (hm); fehm Dr. Neethu Mohan, ms Manager \u2013 Community Outreach & Manager Accounts & Finance Dr. Madhuri, ms, dnb, fico, faico Eye Bank R. Sakthivel, ba Dr. V. Prasanna, ms, fico Rajesh, b.sc, msw, pg.diploma IT & Systems Dr. Nithila EG Paul, do, dnb A. Kumaresan, bca Dr. Preethi G, dnb Manager - Quality Assurance Riyah Jaitika, pgdhm IT & Systems Ajmal Hussain, bca, dce\t ARAVIND-CHENNAI UVEA SERVICES ARAVIND-TIRUPATI Medical Consultant Chief Medical Officer Dr. Eliza Anthony, dnb Chief Medical Officer Dr. S. Aravind, ms, mba Dr. S. Ashok Vardhan, do, dnb ORBIT, OCULOPLASTY AND RETINA-VITREOUS SERVICES OCULAR ONCOLOGY SERVICES RETINA-VITREOUS SERVICES Medical Consultants Chief Chief Dr. Jayashree, do, dnb Dr. Y. C. Venugopal Reddy, ms Dr. Anand Rajendran, dnb, frcs Dr. Vikas Memon, dnb Medical Consultants Dr. Gayatri Fulse, do, dnb Dr. Upendra Babu, ms Medical Consultants Dr. Anupama Joy, do, dnb Dr. A. Joash Rijey, dnb Dr. Karthik Srinivasan, ms Dr. Yasar Safar, ms Dr. Deepak Anthwal, ms Dr. Prabhu Baskaran, ms, dnb Dr. Indu G, ms NEURO-OPHTHALMOLOGY INTRAOCULAR LENS & CATARACT Dr. Chainani Ritesh Mohan, dnb SERVICES SERVICES Dr. Adithya Maitray, ms Medical Consultants Chief Dr. Shruthi Suresh, ms Dr. Nirmala Devy, do Dr. Preeti Mohanty, ms, dnb Dr. Puja Maitra, dnb Dr. Madhumita Gopal, do, dnb Medical Consultants Dr. Umakanth, ms INTRAOCULAR LENS & CATARACT GENERAL OPHTHALMOLOGY Dr. P. Santosh, do Medical Consultants Dr. Sai Silpa M, ms SERVICES Dr. Bina Anna Vurgese, do, dnb, frcs Dr. Kumar Hariharan, ms, dnb, frcs CORNEA & REFRACTIVE SURGERY Chief Dr. Swathija, ms SERVICES Dr. Haripriya Aravind, ms Medical Consultants Dr. V. Raj Yeshwanth, ms Medical Consultants Dr. Biswajit Baral, ms Dr. Anusha Koduru, dnb Dr. Sudha Palaniappan, doms, dnb, \t\t Dr. M. Chaitanya Kumar, ms \t\t\t fico 92","PAEDIATRIC OPHTHALMOLOGY & ARAVIND-TIRUPUR Aravind Integrated ADULT STRABISMUS SERVICES Eye Bank Services Chief Medical Consultants (AIEBS) Dr. Sathya T. Ravilla, ms Dr. Hridya Mohan, ms Medical Consultant Dr. Shinde Vijay Mahadeo, ms Director Dr. Mahima Bankar, ms Dr. Harithra S, do Dr. M. Srinivasan, ms, do, fams Manager GLAUCOMA SERVICES Balaji T, be, mba ROTARY ARAVIND Chief INTERNATIONAL EYE BANK, Dr. S. Ashok Vardhan, do, dnb ARAVIND-DINDIGUL MADURAI Medical Consultants Dr. Sreenath, do, dnb Medical Consultants Technical Director Dr. Keerthi Gayam, dnb Dr. R. Vigneshwar, ms Dr. Lalitha Prajna, md, dnb Dr. K. Venkata Sudheer, dnb Dr. S. Rekha, ms Dr. Modepally Preethy. ms Medical Officer Medical Director Designee Dr. Sangavi Samritha Selvi P, ms Dr. Manoranjan Das, dnb NEURO OPHTHALMOLOGY Dr. S. Preethi, ms SERVICES Manager Manager Medical Consultants R. Balasubramani, m.sc. D. Saravanan, msw, m.phil, mba (hr) Dr. Preeti Mohanty, ms, dnb Dr. P. Bhuvan Kalyan, ms ARAVIND-TUTICORIN pgdc GENERAL OPHTHALMOLOGY Chief Medical Officer ROTARY ARAVIND EYE BANK, SERVICES Dr. G. Anitha, do, dnb TIRUNELVELI Medical Consultants Medical Consultants\t Dr. D.V. Navaneetha, dnb Dr. K. Preethi, do Medical Director Dr. Narasimhasudharshan M, do Dr. S. Gomathi Nayagam, ms Dr. R. Ramakrishnan, ms, do Manager-Patient Care & ORBIT AND OCULOPLASTY Administration\t Medical Director Designee Dr. A. Anila Sarvani, ms N. Mohammed Ghouse, mba Dr. V. Anitha, dnb, faico ANAESTHETIST ARAVIND-UDUMALPET ARAVIND-IOB EYE BANK, Dr. M. Sajith, md COIMBATORE Medical Consultants PHYSICIAN Dr. Rohan Rajan, ms Medical Director Dr. Bollu Keerthi, md Dr. Amartyajit Mukherjee, ms Dr. V. Narendran, do, dnb Dr. Muralikrishnan, ms MICROBIOLOGY Medical Director Designee Dr. Nibandhana G, md ARAVIND-KOVILPATTI Dr. Anitha Raghavan, do, frcs (g) ADMINISTRATION Medical Consultant\t ARAVIND EYE BANK Manager-Administration & Finance Dr. B. Harini Balakrishnan, do, dnb ASSOCIATION OF K. Kesava Kumar, b.sc. b.ed, l.l.b, Manager - Office & Accounts PONDICHERRY Manager-Patient Care N. Joseph Antony Samy, b.com Damien Jacob, mba Medical Director Outreach Camp Manager Dr. Josephine Christy S, ms V. Vasudeva Reddy, dece Medical Director Designee Dr. Kunal A. Mandlik, ms ARAVIND EYE BANK, CHENNAI Medical Director Dr. K. Tiruvengada Krishnan, dnb Medical Director Designee Dr. Seema Ramakrishnan, do, \t\t\t dnb, fico 93","Lions Aravind MOLECULAR GENETICS Aurolab Institute of Community Senior Scientist Managing Director-Emeritus Ophthalmology Dr. P. Sundaresan, m.sc, ph.d Dr. P. Balakrishnan, be, ph.d Grant Administrator Scientist Ln. N.A.K. Gopalakrishnaraja, mjf Dr. A. Vanniarajan, m.sc, ph.d Executive Director Thulasiraj Ravilla, mba IMMUNOLOGY & STEM CELL Managing Director Senior Faculty B.S. Ganesh Babu, m.com BIOLOGY R.D. Sriram, be R. Meenakshi Sundaram, mhm V. Vijayakumar, msw, m.phil Scientists Division Manager-Pharmaceuticals R. Suresh Kumar, ma, pgdhm Sanil Joseph, mha, m.sc Prof. VR. Muthukkaruppan, V. Venkatesa Kannan, m.sc, pgdpmir Dhivya Ramasamy, mba Mohammed Gowth, ma, pgdhm \t\t m.sc, ph.d Asst Division Manager- A. Syed Ali, ma D. Yesunesan, msw Dr. Gowripriya Chidambaranathan, \t Pharmaceuticals B. Udayakumar, msw Administrator \t\t\t m.sc, ph.d Dr. J. Venkateswaran, m.pharm, ph.d G. Krishna Veni, m.sc Division Manager-Intraocular Lens Aravind Medical Research Foundation OCULAR PHARMACOLOGY R. Sundara Ganesh, be President Scientist Division Manager-Suture Needle Dr. P. Namperumalsamy, ms, fams Dr. S. Senthilkumari, m.pharm, ph.d Vice President R.K. Ramnath, be Dr. G. Natchiar, ms, do Secretary & Treasurer PROTEOMICS Division Manager-Surgical Blade Dr. R. Kim, do, dnb Director-Research Director S. Saravanan, be Prof. K. Dharmalingam, m.sc, ph.d Prof. K. Dharmalingam, m.sc, ph.d Advisor-Research Division Manager- Equipment Prof. VR. Muthukkaruppan, m.sc, \t\t Scientists Dr. J. Jeya Maheshwari, m.sc, ph.d B.R. Dinesh, me ph.d Dr. O.G. Ram Prasad, m.sc, ph.d Dr. Daipayan Banerjee, b.tech., ph.d Marketing Manager-Exports N. Vishnu Prasad, mhm, mba Marketing Manager-Domestic S. Sivanand, b.sc, mba MICROBIOLOGY Manager-Regulatory Affairs Clinician Scientists R. Krishna Kumar, b.pharm, ms Dr. Lalitha Prajna, md, dnb Dr. S.R. Rathinam, fams, ph.d Senior Manager-Human Resources Associate Faculty S. Franklinraja, m.a, (p.m & ir) Dr. Siddharth Narendran, ms Manager-Human Resources V. Swetha, mba Manager-IT & Systems BIOINFORMATICS K.R. Sankar, m.sc Scientist Chief Accounts Officer Dr. D. Bharanidharan, m.sc, ph.d M.L.S. Vaithiyanathan, bba, c.a. \t\t PATHOLOGIST \t\t articleship Dr. R. Shanthi, md RAMALINGASWAMI FELLOW Dr. Anwar Azad P, m.sc, ph.d Dr. Swagata Ghosh, m.sc, ph.d 94","ARAVIND EYE HOSPITALS & Postgraduate Institute of Ophthalmology MADURAI - 1, Anna Nagar, Madurai 625 020, Tamil Nadu, India. Phone: (0452) 435 6100 TIRUNELVELI - S.N. High Road, Tirunelveli Jn. 627 001, Tamil Nadu, India. Phone: (0462) 435 6100 COIMBATORE - Avinashi Road, Coimbatore 641 014, Tamil Nadu, India. Phone: (0422) 436 0400 PONDICHERRY - Cuddalore Main Road, Thavalakuppam, Pondicherry 605 007, India. Phone: (0413) 261 9100 SALEM - Sankagiri Main Road, Nethimedu, Salem 636 002, Tamil Nadu, India. Phone: (0427) 235 6100 CHENNAI - Poonamallee High Road, Noombal, Chennai 600 077, Tamil Nadu, India. Phone: (044) 409 56100 TIRUPATI - Alipiri to Zoo Park Road, Beside NCC Campus, Tirupati 517 505, Chittoor District, Andhra Pradesh, India. Phone: (0877) 250 2100, 350 2100 THENI - Periyakulam Road, Theni 625 531, Tamil Nadu, India. Phone: (04546) 252 658 TIRUPUR - Dharapuram Main Road, Chettipalayam Post, Tirupur 641 608, Tamil Nadu, India. Phone: (0421) 226 6100, 87547 28996 DINDIGUL - Old door no 21\/1 Thadicombu Road, Dindigul-624 001, Tamil Nadu, India. Phone: (0451) 244 8100 TUTICORIN - Meenakshipuram West, Near Old Bus Stand, Tuticorin 628 002, Tamil Nadu, India. Phone: (0461) 230 0410 UDUMALPET - 112, Dhalli Road, Opp. Palaniandavar Mills, Udumalpet 642 126, Tamil Nadu, India. Phone: (04252) 260 400 COIMBATORE CITY CENTRE - Cowly Brown Road, R.S. Puram, Coimbatore 641 002, Tamil Nadu, India Phone: (0422) 254 0400 KOVILPATTI - 4\/897, New Appaneri, Padmavathi Garden, Thiruvenkadam Main Road, G.V.N. College (PO), Kovilpatti 628 502, Tamil Nadu, India. Phone: (04632) 290 800, 85258 22027, 85250 66250 LIONS ARAVIND INSTITUTE OF COMMUNITY OPHTHALMOLOGY 72, Kuruvikaran Salai, Gandhinagar, Madurai 625 020, Tamil Nadu, India. Phone: (0452) 435 6500 ARAVIND INTEGRATED EYE BANK SERVICES ROTARY - ARAVIND INTERNATIONAL EYE BANK 1, Anna Nagar, Madurai 625 020, Tamil Nadu, India. Phone: (0452) 435 6100 ROTARY - ARAVIND EYE BANK S.N. High Road, Tirunelveli Jn. 627 001, Tamil Nadu, India. Phone: (0462) 435 6100 IOB - ARAVIND EYE BANK Avinashi Road, Coimbatore 641 014, Tamil Nadu, India. Phone: (0422) 436 0400 ARAVIND EYE BANK ASSOCIATION OF PONDICHERRY Cuddalore Main Road, Thavalakuppam, Pondicherry 605 007, India. Phone: (0413) 261 9100 ARAVIND EYE BANK Poonamallee High Road, Noombal, Chennai 600 077, Tamil Nadu, India. Phone : (044) 409 56100 ARAVIND MEDICAL RESEARCH FOUNDATION DR. G. VENKATASWAMY EYE RESEARCH INSTITUTE 1, Anna Nagar, Madurai 625 020, Tamil Nadu, India. Phone: (0452) 435 6550 AUROLAB 1, Sivagangai Road, Veerapanjan, Madurai 625 020, Tamil Nadu, India. Phone: (0452) 244 6100 ARAVIND EYE CARE SYSTEM www.aravind.org 95","96"]